Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.1214237817523907e-63,91.35478222805865,13148.197897665612,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.6356260616382528e-60,0,0,80
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.876136699625793e-19,7.682177263969171,321.27679474200255,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'COX8A', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'COX6C', 'ATP5F1E', 'COX6B1', 'COX7A2L', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5PO', 'SLC25A5', 'SLC25A4']",1.8015478153019578e-16,0,0,46
3,Nonalcoholic fatty liver disease WP4396,4.591814041245867e-11,3.7787134169065233,89.9491020235923,"['NDUFB9', 'NDUFA13', 'GSK3A', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'PIK3CD', 'NDUFB1', 'IRS2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'SOCS3', 'UQCRFS1', 'CCL2', 'COX8A', 'SREBF1', 'XBP1', 'NDUFA7', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'COX6C', 'COX6B1', 'TNFRSF1A', 'COX7A2L', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'CYCS']",8.020368525376115e-09,0,0,46
4,Oxidative phosphorylation WP623,4.704678796307215e-10,6.600760456273764,141.7664691661334,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'NDUFA7', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5PO']",6.163129223162453e-08,0,0,25
5,Mitochondrial CIV Assembly WP4922,5.778344372540539e-09,9.109633584081534,172.80199347622278,"['COX8A', 'COA3', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'PNKD', 'COX14', 'COA6']",6.055704902422484e-07,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.3659667841028502e-06,4.384502000421142,56.79825875264571,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFAF3']",0.0002066277658116489,0,0,20
7,Vitamin D Receptor Pathway WP2877,1.3893970320354873e-05,3.4453480316857927,38.53296395407842,"['CDKN2D', 'CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'SLC8A1', 'CEACAM1', 'BCL6', 'CREG2', 'S100A6', 'TIMP2', 'SPP1', 'CD9', 'PRKCQ', 'IGSF9B', 'JUNB', 'ABCD1', 'CD200']",0.0010400629211237077,0,0,22
8,Spinal Cord Injury WP2431,5.243442660598272e-05,3.0773413002812657,30.330113329076386,"['RTN4R', 'IL1R1', 'GADD45A', 'MIF', 'PLA2G5', 'AQP1', 'ICAM1', 'GFAP', 'TNFSF13B', 'RHOB', 'FKBP1A', 'LGALS3', 'BCAN', 'ZFP36', 'VCAN', 'GAP43', 'COL4A1', 'CCNG1', 'SLIT1', 'CCL2', 'SLIT3', 'SLIT2']",0.003434454942691868,0,0,22
9,Synaptic Vesicle Pathway WP2267,0.00026576800078734935,3.512841849586182,28.920829319385067,"['SNAP25', 'SLC38A1', 'RAB3A', 'SYT1', 'CACNA1B', 'CLTA', 'CACNA1A', 'SYP', 'SYN3', 'CPLX2', 'CPLX1', 'RIMS1', 'AP2S1', 'SLC25A4', 'VAMP2']",0.015473603601396784,0,0,15
10,Calcium Regulation in the Cardiac Cell WP536,0.0005412479083487442,2.2471085266336823,16.9019259701553,"['CHRM3', 'RYR2', 'YWHAB', 'CAMK2A', 'CACNA1B', 'ATP1A4', 'CACNA1A', 'CACNA1D', 'ADCY2', 'PRKCZ', 'SLC8A1', 'GNAI1', 'RGS4', 'GNG3', 'PLN', 'GNG2', 'GRK5', 'PRKAR2B', 'YWHAG', 'YWHAH', 'ATP1B2', 'ATP1B1', 'YWHAZ', 'FKBP1A', 'PRKAR1A', 'PRKCQ', 'CALM3']",0.028361390397474196,0,0,27
11,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0006084017427228023,3.1719752986105467,23.487446616579117,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'SMAD3', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'ACTB', 'SPP1', 'HES1', 'JUNB', 'HES5']",0.02898204665334076,0,0,15
12,Selenium Micronutrient Network WP15,0.0009335108810715596,3.16329940756494,22.06894159477802,"['SERPINA3', 'GPX4', 'TXN', 'SOD2', 'ICAM1', 'SELENOH', 'SOD1', 'PRDX3', 'SELENOM', 'PRDX5', 'RFK', 'SELENOW', 'CCL2', 'SEPHS2']",0.0407633084734581,0,0,14
13,Differentiation Pathway WP2848,0.0012242604469913168,5.231849529780564,35.08173975791639,"['NT5E', 'KITLG', 'WNT2B', 'NOTCH1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.049347113401803845,0,0,8
14,Cholesterol Biosynthesis Pathway WP197,0.0017686762957753322,5.71984649122807,36.249663657589174,"['FDPS', 'SQLE', 'MVK', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7']",0.06056217230946952,0,0,7
15,Mitochondrial complex III assembly WP4921,0.0017686762957753322,5.71984649122807,36.249663657589174,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.06056217230946952,0,0,7
16,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0018492266354036494,3.040633423180593,19.134668921441577,"['FDPS', 'SREBF1', 'MVK', 'HMGCS1', 'ELOVL4', 'MSMO1', 'DHCR24', 'HMGCR', 'HSD17B7', 'SQLE', 'SCD', 'FASN', 'DHCR7']",0.06056217230946952,0,0,13
17,Nuclear Receptors Meta-Pathway WP2882,0.0031675771703544194,1.7241291175498512,9.921998043867967,"['GSTP1', 'MGST1', 'IRS2', 'DBI', 'SLC2A3', 'TXN', 'AHR', 'SLC5A3', 'CYP3A5', 'AKAP13', 'FTH1', 'ENC1', 'CCL2', 'HES1', 'JUNB', 'CBR3', 'SREBF1', 'NQO1', 'GADD45B', 'SLC6A16', 'SLC6A15', 'HGF', 'STAT3', 'SLC39A11', 'NRG1', 'SLC39A14', 'SLC2A9', 'SCD', 'CDC37', 'FASN', 'SPINK13', 'PMP2', 'ANGPTL4', 'GCLM', 'EPHA2', 'HSPA1A', 'FKBP5', 'FTL']",0.09055535361477222,0,0,38
18,Adipogenesis WP236,0.003195925055907782,2.152309181415929,12.366907482804942,"['WWTR1', 'SREBF1', 'CDKN1A', 'CEBPB', 'SMAD3', 'GADD45B', 'CEBPD', 'GADD45A', 'STAT3', 'IRS2', 'AHR', 'MIF', 'BSCL2', 'SOCS3', 'KLF6', 'SCD', 'NAMPT', 'PNPLA3', 'NDN', 'ID3', 'RXRG']",0.09055535361477222,0,0,21
19,Development and heterogeneity of the ILC family WP3893,0.003283495646337161,8.164111389236545,46.68930129924333,"['NFIL3', 'ZBTB16', 'ID2', 'IL18', 'AHR']",0.09055535361477222,0,0,5
20,Cellular Proteostasis WP4918,0.003749844078048562,13.05691056910569,72.93643802110893,"['VBP1', 'PFDN2', 'PFDN5', 'PFDN6']",0.09824591484487231,0,0,4
21,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.004094040794184897,5.600143125503176,30.790834769401748,"['EGF', 'CD81', 'STAT3', 'SPP1', 'HSPB1', 'SOD1']",0.09997632998462956,0,0,6
22,Complement and Coagulation Cascades WP558,0.00419747950317147,4.575,25.040215063487338,"['CPB2', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'F3', 'KLKB1']",0.09997632998462956,0,0,7
23,Proximal tubule transport WP4917,0.004766248011723532,3.462100524023913,18.509067502115737,"['ATP6V1G1', 'ATP6V0B', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'ATP1B1', 'ATP6V0C', 'AQP1', 'ATP6V1F']",0.10858756339752743,0,0,9
24,IL1 and megakaryocytes in obesity WP2865,0.005851120075820743,6.5306633291614515,33.574938027098355,"['IL1R1', 'IL18', 'TIMP2', 'CCL2', 'ICAM1']",0.12029008234282074,0,0,5
25,Overview of nanoparticle effects WP3287,0.005851120075820743,6.5306633291614515,33.574938027098355,"['CCND3', 'COL4A1', 'LAMA3', 'FN1', 'PIK3CD']",0.12029008234282074,0,0,5
26,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.005968591871972021,1.9763458189285437,10.121349654756601,"['RYR2', 'SNAP25', 'GABRA1', 'CEBPB', 'TSPYL1', 'CAV3', 'CHRNA4', 'YWHAB', 'CHRNA7', 'ATP1A3', 'YWHAZ', 'VEGFA', 'PRKAR1A', 'PRKAR2B', 'PLP1', 'HES1', 'GAPDH', 'SLC25A4', 'YWHAG', 'VAMP2', 'HES5', 'YWHAH']",0.12029008234282074,0,0,22
27,Dual hijack model of Vif in HIV infection WP3300,0.00782924780896966,8.703773191578069,42.21233245780054,"['UBB', 'ELOB', 'ELOC', 'RUNX1']",0.1414664086862104,0,0,4
28,Gene regulatory network modelling somitogenesis  WP2854,0.00782924780896966,8.703773191578069,42.21233245780054,"['LFNG', 'RIPPLY2', 'NOTCH1', 'HES1']",0.1414664086862104,0,0,4
29,Mevalonate pathway WP3963,0.00782924780896966,8.703773191578069,42.21233245780054,"['FDPS', 'MVK', 'HMGCS1', 'HMGCR']",0.1414664086862104,0,0,4
30,Glycolysis and Gluconeogenesis WP534,0.008233871641821692,3.097074555900416,14.86440606225474,"['LDHA', 'TPI1', 'MDH1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'SLC2A3', 'GAPDH']",0.14381829134381888,0,0,9
31,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.014019876110604021,6.527204502814259,27.853404231149668,"['CDKN1A', 'SPP1', 'FAM20C', 'FGFR3']",0.23214065769647985,0,0,4
32,Cori Cycle WP1946,0.014619545236610371,4.663865546218488,19.706678500376228,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'GAPDH']",0.23214065769647985,0,0,5
33,Differentiation of white and brown adipocyte WP2895,0.014619545236610371,4.663865546218488,19.706678500376228,"['SMAD1', 'CEBPB', 'ZIC1', 'SMAD9', 'SLC7A10']",0.23214065769647985,0,0,5
34,Genotoxicity pathway WP4286,0.015706673908353175,2.39784338358459,9.959849089424399,"['ACTA2', 'ITPKC', 'PLK3', 'CDKN1A', 'RPS27', 'DAAM1', 'CEBPD', 'GADD45A', 'BLOC1S2', 'ID2', 'TRIM22']",0.2351513465136304,0,0,11
35,Pathogenic Escherichia coli infection WP2272,0.015706673908353175,2.39784338358459,9.959849089424399,"['TUBA1B', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB', 'NCL', 'ARPC5L', 'YWHAZ', 'ACTB', 'ACTG1']",0.2351513465136304,0,0,11
36,Complement system WP2806,0.01663590660384324,2.6739762746663627,10.953119880114345,"['RPS19', 'C1S', 'C1R', 'PROS1', 'SPP1', 'SERPING1', 'TXN', 'KLKB1', 'ICAM1']",0.24214486278927386,0,0,9
37,Globo Sphingolipid Metabolism WP1424,0.018446574061923144,3.5623612455171627,14.224068905844552,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT', 'ST6GALNAC5']",0.2501588649402811,0,0,6
38,Striated Muscle Contraction Pathway WP383,0.018446574061923144,3.5623612455171627,14.224068905844552,"['ACTA2', 'ACTN2', 'TPM3', 'TPM2', 'TCAP', 'ACTG1']",0.2501588649402811,0,0,6
39,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.019096096560326802,9.7865625,38.73786979612998,"['COX8A', 'GSTP1', 'COX5A']",0.2501588649402811,0,0,3
40,Liver X receptor pathway WP2874,0.019096096560326802,9.7865625,38.73786979612998,"['SREBF1', 'SCD', 'FASN']",0.2501588649402811,0,0,3
41,Hematopoietic Stem Cell Differentiation WP2849,0.02022991983546266,3.048538011695906,11.891104780176997,"['HES6', 'CIITA', 'KITLG', 'NOTCH1', 'PIM1', 'NFATC2', 'RUNX1']",0.252392333185296,0,0,7
42,Type II interferon signaling (IFNG) WP619,0.02022991983546266,3.048538011695906,11.891104780176997,"['SOCS3', 'CIITA', 'HLA-B', 'GBP1', 'IRF9', 'ICAM1', 'PSMB9']",0.252392333185296,0,0,7
43,Folate Metabolism WP176,0.020743032432756815,2.7512291701039433,10.662512110332447,"['DHFR', 'SERPINA3', 'GPX4', 'RFK', 'CCL2', 'SOD2', 'ICAM1', 'SOD1']",0.25277555801778073,0,0,8
44,Myometrial relaxation and contraction pathways WP289,0.021334043684900723,1.7157163940845155,6.601135077173497,"['RYR2', 'OXTR', 'YWHAB', 'CAMK2A', 'ADCY2', 'PRKCZ', 'YWHAZ', 'SLC8A1', 'ACTB', 'ACTG1', 'RGS4', 'ACTA2', 'GNG3', 'GNG2', 'GRK5', 'PRKAR1A', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.2540690657019995,0,0,22
45,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.022609000331008065,5.2212632895559725,19.78549274037974,"['GRM3', 'GRM5', 'GRM8', 'GRM1']",0.25754600377061365,0,0,4
46,Nicotine Activity on Dopaminergic Neurons WP1602,0.022609000331008065,5.2212632895559725,19.78549274037974,"['GNG2', 'CHRNA4', 'ADCY2', 'GNAI1']",0.25754600377061365,0,0,4
47,NRF2 pathway WP2884,0.026075975322778895,1.785202179523946,6.510169756919976,"['NQO1', 'SLC6A16', 'HGF', 'SLC6A15', 'GSTP1', 'SLC39A11', 'SLC2A3', 'NRG1', 'TXN', 'SLC5A3', 'SLC39A14', 'SLC2A9', 'FTH1', 'GCLM', 'FTL', 'EPHA2', 'CBR3', 'HSPA1A']",0.29071938444970513,0,0,18
48,"GPCRs, Other WP117",0.03204394682650335,3.0137276624440057,10.369172980392971,"['CHRM3', 'EDNRA', 'GRM8', 'GRM1', 'ADGRL2', 'GPR135']",0.3166282300182772,0,0,6
49,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.03261184662076785,2.0117004303050816,6.886210831721184,"['CDKN1A', 'DAAM1', 'SHC1', 'FZD4', 'TMSB4X', 'FN1', 'NEFL', 'NEFM', 'PFN1', 'NEFH', 'PFN2', 'SOD1']",0.3166282300182772,0,0,12
50,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03348508942834746,1.3235351685681602,4.495592388923137,"['RPL5', 'ARPC5L', 'HSPB1', 'NRARP', 'LDB2', 'SHB', 'RPL10A', 'SLC8A1', 'RPL7', 'ICAM1', 'ACTG1', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'TPM3', 'RPS6', 'RPL13A', 'F3', 'RCN1', 'NCL', 'TXNIP', 'MYH9', 'RPL27', 'RPL26', 'PFN1', 'GAPDH', 'VCL', 'ARF6', 'EPHA2', 'SET', 'SHC1', 'PLA2G5', 'TXN', 'PRKCZ', 'NDRG1', 'APOLD1', 'LDHA', 'AP2S1', 'PGK1', 'CCL2', 'SDF2L1', 'STAT3', 'FN1', 'NFATC2', 'BMX', 'SOD2', 'RAB11A', 'VEGFA', 'P4HA2', 'CYCS', 'HSPA1A']",0.3166282300182772,0,0,60
51,Computational Model of Aerobic Glycolysis WP4629,0.03378094051105693,4.350635814050448,14.739338635039976,"['LDHA', 'TPI1', 'PGK1', 'GAPDH']",0.3166282300182772,0,0,4
52,ID signaling pathway WP53,0.03378094051105693,4.350635814050448,14.739338635039976,"['SREBF1', 'ID2', 'ID3', 'ELK3']",0.3166282300182772,0,0,4
53,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.03378094051105693,4.350635814050448,14.739338635039976,"['FDPS', 'MVK', 'HMGCS1', 'HMGCR']",0.3166282300182772,0,0,4
54,miR-509-3p alteration of YAP1/ECM axis WP3967,0.03378094051105693,4.350635814050448,14.739338635039976,"['EDNRA', 'PBX3', 'FN1', 'TEAD3']",0.3166282300182772,0,0,4
55,HIF1A and PPARG regulation of glycolysis WP2456,0.03444238379969809,6.52375,21.97503910810503,"['LDHA', 'TPI1', 'GAPDH']",0.3166282300182772,0,0,3
56,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.03444238379969809,6.52375,21.97503910810503,"['SOCS3', 'STAT3', 'CHI3L1']",0.3166282300182772,0,0,3
57,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.03444238379969809,6.52375,21.97503910810503,"['LFNG', 'RIPPLY2', 'NOTCH1']",0.3166282300182772,0,0,3
58,"GPCRs, Class A Rhodopsin-like WP455",0.03581321014369504,2.2617266673101053,7.530279741319438,"['P2RY12', 'CHRM3', 'OXTR', 'EDNRA', 'P2RY14', 'GPR87', 'GPR171', 'ACKR4', 'GPR37L1']",0.32355382957407247,0,0,9
59,Cardiac Progenitor Differentiation WP2406,0.039441850864876324,3.263767209011264,10.551523813650155,"['MESP1', 'SOX1', 'NOTCH1', 'NRG1', 'THY1']",0.3444588308865865,0,0,5
60,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.039441850864876324,3.263767209011264,10.551523813650155,"['SREBF1', 'HMGCS1', 'SCD', 'FASN', 'HMGCR']",0.3444588308865865,0,0,5
61,Vitamin B12 metabolism WP1533,0.04077522673220935,2.798193040522408,8.953323902648593,"['SERPINA3', 'CCL2', 'APOE', 'SOD2', 'ICAM1', 'SOD1']",0.3502658820930771,0,0,6
62,Pyrimidine metabolism WP4022,0.04458114353798176,1.7516980028787335,5.448559068350118,"['ENTPD3', 'NME2', 'NME3', 'DCK', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLE3', 'POLR2E', 'ENPP3', 'POLR2I', 'DCTPP1', 'POLR2K', 'POLR2L']",0.3735904879287425,0,0,15
63,Exercise-induced Circadian Regulation WP410,0.04525687610710465,2.041941305712492,6.320626469901742,"['CEBPB', 'SUMO1', 'RBPMS', 'PPP1R3C', 'TUBB3', 'GSTP1', 'SUMO3', 'TAB2', 'ERC2', 'ETV6']",0.3735904879287425,0,0,10
64,Aryl Hydrocarbon Receptor Netpath WP2586,0.045629372571449466,2.271882240697833,7.0137631106136284,"['NQO1', 'CDKN1A', 'KLF6', 'PSRC1', 'CDC37', 'AHR', 'HRAS', 'VEGFA']",0.3735904879287425,0,0,8
65,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.047620216382257344,3.7287590458322164,11.352199062259261,"['RYR2', 'CD38', 'CCK', 'GNAI1']",0.3780756573379219,0,0,4
66,Hypertrophy Model WP516,0.047620216382257344,3.7287590458322164,11.352199062259261,"['WDR1', 'IL1R1', 'IL18', 'VEGFA']",0.3780756573379219,0,0,4
67,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.048406349901918624,13.041848844472204,39.492339110010704,"['NRP1', 'VEGFA']",0.3785810052030651,0,0,2
68,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0522120539165286,1.9798740702695505,5.845463147551729,"['BEX3', 'SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'RNF7', 'APOE', 'YBX3']",0.39569285053307157,0,0,10
69,Disruption of postsynaptic signaling by CNV WP4875,0.05401068897987827,2.1770114942528735,6.35376763819279,"['RPH3A', 'RYR2', 'CAMK2A', 'NRXN3', 'DLGAP1', 'GRM1', 'YWHAG', 'SHANK1']",0.39569285053307157,0,0,8
70,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.05440226716954978,4.89234375,14.243322286154136,"['HEY1', 'HES1', 'VEGFA']",0.39569285053307157,0,0,3
71,Osteoclast Signaling WP12,0.05440226716954978,4.89234375,14.243322286154136,"['ATP6V1G1', 'SPP1', 'TNFRSF11B']",0.39569285053307157,0,0,3
72,Transcriptional cascade regulating adipogenesis WP4211,0.05440226716954978,4.89234375,14.243322286154136,"['SREBF1', 'CEBPB', 'CEBPD']",0.39569285053307157,0,0,3
73,Senescence and Autophagy in Cancer WP615,0.055125149024645465,1.6909689047164076,4.900680249151566,"['GABARAPL2', 'GABARAPL1', 'CDKN1A', 'CEBPB', 'SMAD3', 'FN1', 'CXCL14', 'GABARAP', 'IGF1R', 'MAP1LC3A', 'IFI16', 'FKBP8', 'IRF7', 'HRAS', 'CD44']",0.39569285053307157,0,0,15
74,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.06236102171872783,2.447949279899812,6.792606015691307,"['NDUFA13', 'ACAP1', 'IL18', 'ERBIN', 'NOD1', 'NLRP1']",0.4308658769884668,0,0,6
75,Vitamin A and carotenoid metabolism WP716,0.06236102171872783,2.447949279899812,6.792606015691307,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1']",0.4308658769884668,0,0,6
76,Ferroptosis WP4313,0.06331426054983195,2.089730407523511,5.76691342277389,"['MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'GCLM', 'CP', 'SLC39A14', 'FTL']",0.4308658769884668,0,0,8
77,IL-2 signaling pathway WP49,0.06331426054983195,2.089730407523511,5.76691342277389,"['SOCS3', 'CCND2', 'SHC1', 'STAT3', 'RPS6', 'NMI', 'GAB2', 'HRAS']",0.4308658769884668,0,0,8
78,Ovarian infertility WP34,0.06494803518680281,2.7192845223195663,7.434980145942409,"['CEBPB', 'CCND2', 'SMAD3', 'INHA', 'SYNE2']",0.4363175697164702,0,0,5
79,Interferon type I signaling pathways WP585,0.06815789924748003,1.8663796968881714,5.012961893067576,"['IFNAR2', 'SOCS3', 'RPS6', 'STAT3', 'PDCD4', 'PIK3CD', 'IRS2', 'GAB2', 'IRF9', 'EIF4B']",0.4483655484699743,0,0,10
80,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.06919564200231089,1.7424680494447937,4.653813977014466,"['PSMD10', 'TUBA1B', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'RNF19A', 'TUBB', 'STUB1', 'HSPA1B', 'SNCA', 'HSPA1A']",0.4483655484699743,0,0,12
81,The influence of laminopathies on Wnt signaling WP4844,0.06930841493524412,2.1762740183792815,5.808886567516502,"['SREBF1', 'CEBPB', 'CEBPD', 'SPP1', 'HMGA2', 'HES1', 'HES5']",0.4483655484699743,0,0,7
82,Aryl Hydrocarbon Receptor Pathway WP2873,0.07525553419973582,2.30373126081992,5.959443689044497,"['NQO1', 'CDC37', 'MGST1', 'HES1', 'AHR', 'JUNB']",0.475107227959778,0,0,6
83,Lung fibrosis WP3624,0.07525553419973582,2.30373126081992,5.959443689044497,"['CEBPB', 'EGF', 'HGF', 'SPP1', 'CCL2', 'ATP11A']",0.475107227959778,0,0,6
84,Phytochemical activity on NRF2 transcriptional activation WP3,0.08319728461307532,2.899590021541241,7.209948220724031,"['NQO1', 'CEBPB', 'MAF', 'GCLM']",0.5189925849672794,0,0,4
85,Blood Clotting Cascade WP272,0.08833570080364095,6.5202998126171146,15.822230860457662,"['F3', 'KLKB1']",0.5382314793152077,0,0,2
86,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.08833570080364095,6.5202998126171146,15.822230860457662,"['SLIT2', 'VEGFA']",0.5382314793152077,0,0,2
87,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.09446995852732136,1.986651411136537,4.687451148136241,"['GABRA1', 'SLC12A5', 'SHC1', 'GABRA4', 'STAT3', 'GABRD', 'GABRG3']",0.5689914743484643,0,0,7
88,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.10470097253235588,2.6093808630393998,5.888451163469352,"['BCL2L2', 'ICAM1', 'VEGFA', 'TNFRSF1A']",0.6074020886583179,0,0,4
89,GABA receptor Signaling WP4159,0.1051924587856761,2.0608377550011534,4.640931745360708,"['GABRA1', 'GAD1', 'GABRA4', 'AP2S1', 'GABRD', 'GABRG3']",0.6074020886583179,0,0,6
90,Dopamine metabolism WP2436,0.10664311480260542,3.2609375,7.29885008325784,"['NQO1', 'MAOB', 'SOD1']",0.6074020886583179,0,0,3
91,Glutathione metabolism WP100,0.10664311480260542,3.2609375,7.29885008325784,"['GPX4', 'OPLAH', 'GCLM']",0.6074020886583179,0,0,3
92,NOTCH1 regulation of endothelial cell calcification WP3413,0.10664311480260542,3.2609375,7.29885008325784,"['NOTCH1', 'FGFR3', 'VEGFA']",0.6074020886583179,0,0,3
93,TGF-beta Receptor Signaling WP560,0.10990782178257469,1.8007999135228623,3.9763701465678576,"['FKBP1A', 'SMAD1', 'SMAD3', 'EGF', 'STAT3', 'SPP1', 'SMAD9', 'HRAS']",0.6192655764953671,0,0,8
94,Ectoderm Differentiation WP2858,0.11413683967315959,1.411178546831956,3.0627615230161394,"['ELOVL4', 'TSC22D1', 'FZD4', 'ZBTB16', 'ARHGDIG', 'HMGB2', 'TNFRSF11B', 'SORCS1', 'LDB2', 'JAKMIP1', 'CLDN11', 'TRPM2', 'PODXL', 'BOC', 'PIM1', 'CCL2', 'KIFC3', 'LY6E', 'SNCA']",0.6323574302135936,0,0,19
95,Apoptosis Modulation and Signaling WP1772,0.11464495395093775,1.5674670018856065,3.3950007354302323,"['TNFRSF6B', 'CAPNS1', 'IL1R1', 'BAG3', 'TOLLIP', 'TNFRSF10B', 'CYCS', 'TNFRSF11B', 'MAP3K14', 'BCL2L2', 'TNFRSF1A', 'HSPA1A']",0.6323574302135936,0,0,12
96,Oxidative Stress WP408,0.11673787473326909,2.174801835627868,4.671092109546733,"['NQO1', 'MGST1', 'SOD2', 'JUNB', 'SOD1']",0.6356960936073531,0,0,5
97,G Protein Signaling Pathways WP35,0.11767656694639933,1.4992417130064273,3.208100469684378,"['ADCY2', 'AKAP5', 'PRKCZ', 'GNAI1', 'AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PPP3CC', 'PRKAR1A', 'PRKAR2B', 'PRKCQ', 'PDE8B', 'HRAS']",0.6356960936073531,0,0,14
98,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.12027367242428667,1.6322975517890772,3.457182594190376,"['IFI27L2', 'CAMK2A', 'PLCG2', 'PLCE1', 'CCL2', 'PRKCQ', 'HRAS', 'PRKCZ', 'RXRG', 'TNFRSF1A']",0.6430959627584308,0,0,10
99,Amyotrophic lateral sclerosis (ALS) WP2447,0.12403238656154861,1.8273684210526315,3.8141063302759517,"['CST3', 'PPP3CC', 'NEFL', 'NEFM', 'NEFH', 'SOD1', 'TNFRSF1A']",0.6564946521035503,0,0,7
100,TNF-alpha signaling pathway WP231,0.12754809464596537,1.4749182890436265,3.0372428503376527,"['OTUD7B', 'PYGL', 'KSR2', 'TXN', 'PRKCZ', 'TNFRSF1A', 'RFK', 'CDC37', 'CCL2', 'TAB2', 'RFFL', 'HRAS', 'MAP3K14', 'SKP1']",0.6567614863329049,0,0,14
101,Nucleotide metabolism WP404,0.1284315739099402,2.3719370060833476,4.868066297992825,"['DHFR', 'NME2', 'HPRT1', 'OAZ1']",0.6567614863329049,0,0,4
102,Statin inhibition of cholesterol production WP430,0.1284315739099402,2.3719370060833476,4.868066297992825,"['SQLE', 'APOC1', 'HMGCR', 'APOE']",0.6567614863329049,0,0,4
103,Gastric acid production WP2596,0.13309505905590904,inf,inf,['CCK'],0.6567614863329049,0,0,1
104,miR-517 relationship with ARCN1 and USP1 WP3596,0.1344954727451452,4.346450135332084,8.719955794392714,"['CDKN1A', 'ID2']",0.6567614863329049,0,0,2
105,PTF1A related regulatory pathway WP4147,0.1344954727451452,4.346450135332084,8.719955794392714,"['NOTCH1', 'HES1']",0.6567614863329049,0,0,2
106,Heart Development WP1591,0.13732137034475284,2.038681163954944,4.047661457314969,"['SMAD1', 'NOTCH1', 'HEY1', 'NFATC2', 'VEGFA']",0.6567614863329049,0,0,5
107,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.13732137034475284,2.038681163954944,4.047661457314969,"['RAB3A', 'HSPB1', 'NEFL', 'NDRG1', 'RAB11A']",0.6567614863329049,0,0,5
108,FOXA2 pathway WP5066,0.13786977766530445,2.794821428571429,5.537786844449286,"['SREBF1', 'FASN', 'IRS2']",0.6567614863329049,0,0,3
109,Galanin receptor pathway WP4970,0.13786977766530445,2.794821428571429,5.537786844449286,"['CDKN1A', 'VAMP2', 'VEGFA']",0.6567614863329049,0,0,3
110,Matrix Metalloproteinases WP129,0.13786977766530445,2.794821428571429,5.537786844449286,"['MMP15', 'MMP17', 'TIMP2']",0.6567614863329049,0,0,3
111,IL17 signaling pathway WP2112,0.14036569171255084,1.8642096788621523,3.6603834936231077,"['CEBPB', 'CEBPD', 'STAT3', 'IL17RE', 'MAP3K14', 'IL17RB']",0.6626272293457355,0,0,6
112,Cell cycle WP179,0.14287847378519342,1.4198882926295038,2.762763042234427,"['CDKN2D', 'ANAPC13', 'CDKN1A', 'SMAD3', 'GADD45B', 'GADD45A', 'YWHAB', 'CDC7', 'YWHAZ', 'ANAPC11', 'CCND3', 'CCND2', 'YWHAG', 'SKP1', 'YWHAH']",0.6637916012687227,0,0,15
113,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.14314589874688105,1.4636629798308394,2.8452011440683354,"['SHC1', 'EGF', 'HGF', 'RPS6', 'STAT3', 'PIK3CD', 'NRG1', 'IGF1R', 'VEGFA', 'MRAS', 'PLCG2', 'HRAS', 'FGFR3']",0.6637916012687227,0,0,13
114,Osteoblast differentiation WP4787,0.15466946224124395,1.4387165547383007,2.6853140090981276,"['HES6', 'SMAD1', 'NOTCH1', 'WNT2B', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PRKCZ', 'HEY1', 'PRKCQ', 'FGFR3']",0.710936826442209,0,0,13
115,Prader-Willi and Angelman Syndrome WP3998,0.15974495389496982,1.7793021005294016,3.263554586249487,"['CCND2', 'SNRPN', 'NDN', 'GABRG3', 'PRKCZ', 'GABRD']",0.7198224673726337,0,0,6
116,Oncostatin M Signaling Pathway WP2374,0.1597477803849746,1.517978364647659,2.784213800951465,"['SOCS3', 'CEBPB', 'SHC1', 'RPS6', 'STAT3', 'CCL2', 'OSMR', 'JUNB', 'HRAS', 'VEGFA']",0.7198224673726337,0,0,10
117,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.1653721547143684,1.545714191375553,2.7816005793911005,"['RYR2', 'ACTN2', 'ACTN1', 'CACNA1D', 'CACNG2', 'SLC8A1', 'ACTB', 'DSC2', 'ACTG1']",0.7198224673726337,0,0,9
118,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.170853387566928,1.5819131756435831,2.795160651863942,"['FKBP1A', 'SMAD1', 'SMAD3', 'EGF', 'STAT3', 'SPP1', 'SMAD9', 'HRAS']",0.7198224673726337,0,0,8
119,Fatty acid transporters WP5061,0.171713374850342,2.445234375,4.308328421779069,"['FABP3', 'FABP5', 'DBI']",0.7198224673726337,0,0,3
120,Glycolysis in senescence WP5049,0.171713374850342,2.445234375,4.308328421779069,"['LDHA', 'PGK1', 'GAPDH']",0.7198224673726337,0,0,3
121,Imatinib and Chronic Myeloid Leukemia WP3640,0.171713374850342,2.445234375,4.308328421779069,"['GADD45A', 'PIM1', 'GAB2']",0.7198224673726337,0,0,3
122,Kynurenine Pathway and links to Cellular Senescence WP5044,0.171713374850342,2.445234375,4.308328421779069,"['CDKN1A', 'AADAT', 'AHR']",0.7198224673726337,0,0,3
123,Leptin Insulin Overlap WP3935,0.171713374850342,2.445234375,4.308328421779069,"['SOCS3', 'STAT3', 'IRS2']",0.7198224673726337,0,0,3
124,TP53 network WP1742,0.171713374850342,2.445234375,4.308328421779069,"['CDKN1A', 'SUMO1', 'GADD45A']",0.7198224673726337,0,0,3
125,Type II diabetes mellitus WP1584,0.171713374850342,2.445234375,4.308328421779069,"['SURF1', 'CACNA1A', 'PRKCZ']",0.7198224673726337,0,0,3
126,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.18130306034309263,1.4359422110552764,2.4519937844941637,"['SREBF1', 'FDPS', 'SQLE', 'GSK3A', 'HMGCS1', 'MDH1', 'SCD', 'FASN', 'DBI', 'HMGCR', 'SEC24D']",0.7495313771625526,0,0,11
127,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.18452203750757495,3.259525296689569,5.50855335063738,"['SMAD1', 'SMAD9']",0.7495313771625526,0,0,2
128,Complement Activation WP545,0.18452203750757495,3.259525296689569,5.50855335063738,"['C1S', 'C1R']",0.7495313771625526,0,0,2
129,Farnesoid X receptor pathway WP2879,0.18452203750757495,3.259525296689569,5.50855335063738,"['IRS2', 'FKBP5']",0.7495313771625526,0,0,2
130,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.18917410597569093,1.4502336611564484,2.4147659301391697,"['CCND3', 'GNG2', 'RPS6', 'STAT3', 'ADCY2', 'HRAS', 'RALGDS', 'GNAI1', 'IGF1R', 'MYL12B']",0.7625171656250926,0,0,10
131,Prolactin Signaling Pathway WP2037,0.19568030019364172,1.4076510000985318,2.2962631725572016,"['SOCS3', 'SHC1', 'RPS6KA2', 'RPS6', 'STAT3', 'IRS2', 'GAB2', 'HRAS', 'YWHAZ', 'PPIA', 'YWHAG']",0.7767914947080928,0,0,11
132,Retinoblastoma gene in cancer WP2446,0.19568030019364172,1.4076510000985318,2.2962631725572016,"['BARD1', 'DHFR', 'CDKN1A', 'CCND3', 'H2AFZ', 'RPA3', 'STMN1', 'RBP1', 'HMGB2', 'CDC7', 'DCK']",0.7767914947080928,0,0,11
133,CAMKK2  Pathway WP4874,0.2016344648213615,1.6307138384470883,2.6112601141834575,"['CHRM3', 'FIS1', 'MAP1LC3A', 'MAF', 'NFATC2', 'ICAM1']",0.7884810415402494,0,0,6
134,Type 2 papillary renal cell carcinoma WP4241,0.2016344648213615,1.6307138384470883,2.6112601141834575,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB', 'ELOC', 'VEGFA']",0.7884810415402494,0,0,6
135,IL-4 signaling pathway WP395,0.2060116864572211,1.491231527093596,2.355880942391733,"['SOCS3', 'CEBPB', 'NFIL3', 'SHC1', 'STAT3', 'PIK3CD', 'IRS2', 'GAB2']",0.7985491515261443,0,0,8
136,Neovascularisation processes WP4331,0.20725703169380844,1.7162900994664383,2.701089733035062,"['SMAD1', 'KITLG', 'NOTCH1', 'SMAD3', 'SMAD9']",0.7985491515261443,0,0,5
137,EGF/EGFR signaling pathway WP437,0.2114676408212656,1.2385766319876115,1.9243558173486872,"['NDUFA13', 'SHC1', 'EGF', 'LIMK2', 'CAMK2A', 'STAT3', 'PEBP1', 'NEDD8', 'GAB2', 'PTPN12', 'PRKCZ', 'PLSCR1', 'RPS6KA2', 'NEDD4', 'CFL1', 'STMN1', 'AP2S1', 'PLCE1', 'RALGDS', 'HRAS', 'SH3GL2', 'ARF6']",0.7997841616724832,0,0,22
138,Focal Adhesion WP306,0.2114676408212656,1.2385766319876115,1.9243558173486872,"['CAV3', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'RASGRF1', 'LAMA3', 'FN1', 'PIK3CD', 'ACTB', 'MYL12B', 'VEGFA', 'ACTG1', 'IGF1R', 'MYL5', 'CCND3', 'CCND2', 'COL4A1', 'SPP1', 'PAK3', 'HRAS', 'VCL']",0.7997841616724832,0,0,22
139,miRNA regulation of DNA damage response WP1530,0.21435038888978747,1.4322000183615387,2.205793221958115,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'CCNG1', 'TNFRSF10B', 'CYCS', 'PML']",0.7997841616724832,0,0,9
140,Notch Signaling Pathway Netpath WP61,0.21435038888978747,1.4322000183615387,2.205793221958115,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HEY1', 'STAT3', 'HES1', 'HES5', 'SKP1']",0.7997841616724832,0,0,9
141,Hippo-Merlin Signaling Dysregulation WP4541,0.21520909693858803,1.3502243221569605,2.0741405838175377,"['PPP1R14A', 'PRKAR1A', 'PRKAR2B', 'CDH12', 'PAK3', 'FGFR3', 'HRAS', 'CDH18', 'CD44', 'IGF1R', 'EPHA2', 'TEAD3']",0.7997841616724832,0,0,12
142,Ras signaling WP4223,0.23168165983896752,1.2242019595448799,1.7902619344930217,"['SHC1', 'RASGRF1', 'PIK3CD', 'PLA2G5', 'KSR2', 'GAB2', 'IGF1R', 'GNG3', 'MRAS', 'GNG2', 'RASA4', 'PLCG2', 'PLCE1', 'CALM3', 'RAPGEF5', 'PAK3', 'RALGDS', 'FGFR3', 'HRAS', 'EPHA2', 'ARF6']",0.8028993480570511,0,0,21
143,p53 transcriptional gene network WP4963,0.23183052140216134,1.397965585230328,2.043474356538158,"['CDKN1A', 'NOTCH1', 'GADD45A', 'ADGRB1', 'CCNG1', 'CCL2', 'IRF9', 'PML', 'ICAM1']",0.8028993480570511,0,0,9
144,Endochondral Ossification with Skeletal Dysplasias WP4808,0.23545650097991935,1.4728353140916808,2.1300572786716825,"['HMGCS1', 'ADAMTS1', 'SPP1', 'SLC38A2', 'FGFR3', 'IGF1R', 'VEGFA']",0.8028993480570511,0,0,7
145,Endochondral Ossification WP474,0.23545650097991935,1.4728353140916808,2.1300572786716825,"['HMGCS1', 'ADAMTS1', 'SPP1', 'SLC38A2', 'FGFR3', 'IGF1R', 'VEGFA']",0.8028993480570511,0,0,7
146,IL-3 signaling pathway WP286,0.23545650097991935,1.4728353140916808,2.1300572786716825,"['YWHAB', 'SHC1', 'STAT3', 'PIK3CD', 'ENPP3', 'GAB2', 'HRAS']",0.8028993480570511,0,0,7
147,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.23656995394251265,2.60737039350406,3.758553954477272,"['DHCR24', 'DHCR7']",0.8028993480570511,0,0,2
148,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.23656995394251265,2.60737039350406,3.758553954477272,"['ID2', 'STAT3']",0.8028993480570511,0,0,2
149,Glial Cell Differentiation WP2276,0.23656995394251265,2.60737039350406,3.758553954477272,"['GAP43', 'PLP1']",0.8028993480570511,0,0,2
150,"GPCRs, Class B Secretin-like WP334",0.23656995394251265,2.60737039350406,3.758553954477272,"['ADGRG2', 'ADGRL2']",0.8028993480570511,0,0,2
151,Nanoparticle triggered regulated necrosis WP2513,0.23656995394251265,2.60737039350406,3.758553954477272,"['TNFRSF1A', 'FTL']",0.8028993480570511,0,0,2
152,Platelet-mediated interactions with vascular and circulating cells WP4462,0.23656995394251265,2.60737039350406,3.758553954477272,"['CCL2', 'ICAM1']",0.8028993480570511,0,0,2
153,Ebola Virus Pathway on Host WP4217,0.2375494945521456,1.2713860446857927,1.8274639563746404,"['CAV3', 'ACTN1', 'HLA-B', 'CLTB', 'CLTA', 'PIK3CD', 'ACTB', 'ASGR1', 'IGF1R', 'ACTG1', 'HLA-E', 'RHOB', 'SOCS3', 'NEDD4', 'IRF7']",0.8028993480570511,0,0,15
154,7-oxo-C and 7beta-HC pathways WP5064,0.24056335428426912,1.7387533875338754,2.4773267880614447,"['HSD11B1', 'DBP', 'DHCR7', 'ACOT6']",0.8028993480570511,0,0,4
155,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.24056335428426912,1.7387533875338754,2.4773267880614447,"['H3F3B', 'BCL6', 'H2AFJ', 'H2AFZ']",0.8028993480570511,0,0,4
156,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.24056335428426912,1.7387533875338754,2.4773267880614447,"['TTC9', 'CEBPB', 'TPM3', 'ATP2C2']",0.8028993480570511,0,0,4
157,TYROBP causal network in microglia WP3945,0.24056335428426912,1.7387533875338754,2.4773267880614447,"['MAF', 'IL18', 'SPP1', 'IL13RA1']",0.8028993480570511,0,0,4
158,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.24489176219042852,1.9558125,2.7517087910766467,"['GSK3A', 'BCL2L14', 'BCL2L2']",0.8070646753948714,0,0,3
159,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.24489176219042852,1.9558125,2.7517087910766467,"['NQO1', 'CDC37', 'FN1']",0.8070646753948714,0,0,3
160,Hepatitis C and Hepatocellular Carcinoma WP3646,0.24698957869435573,1.5049853089928231,2.1045852037828015,"['CDKN1A', 'SMAD3', 'PODXL', 'STAT3', 'CD44', 'VEGFA']",0.808890870224015,0,0,6
161,Oxidative Damage WP3941,0.259110816676365,1.5525359079802135,2.0966988823412733,"['CDKN1A', 'C1S', 'C1R', 'GADD45A', 'CYCS']",0.8433171921640699,0,0,5
162,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.26452541124285983,1.2389599209259319,1.6475911540057908,"['NOTCH1', 'SMAD3', 'WNT2B', 'SHC1', 'FZD4', 'WNT7B', 'FN1', 'PIK3CD', 'WNT7A', 'CLDN11', 'CLDN20', 'COL4A1', 'MMP15', 'ID2', 'HRAS']",0.8523878732479166,0,0,15
163,Breast cancer pathway WP4262,0.2651511895790275,1.2283331480040032,1.6305570882697968,"['CDKN1A', 'NOTCH1', 'WNT2B', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'IGF1R', 'HEY1', 'HES1', 'HRAS', 'HES5', 'SKP1']",0.8523878732479166,0,0,16
164,DNA Mismatch Repair WP531,0.2715197232295399,1.6299249530956847,2.1249665696520847,"['POLE4', 'POLD4', 'RPA3', 'POLE3']",0.8659954209461144,0,0,4
165,Pathways Regulating Hippo Signaling WP4540,0.2742360173197763,1.2813509511844938,1.6577685077820692,"['SMAD3', 'PRKAR1A', 'PRKAR2B', 'CDH12', 'PRKCQ', 'PRKCZ', 'FGFR3', 'CDH18', 'IGF1R', 'EPHA2', 'TEAD3']",0.8659954209461144,0,0,11
166,Regulation of Actin Cytoskeleton WP51,0.2784482194950585,1.2057472997423104,1.5415758518194895,"['CHRM3', 'EGF', 'ACTN1', 'FN1', 'BRK1', 'PIK3CD', 'ACTB', 'ACTG1', 'MRAS', 'TMSB4X', 'CFL1', 'PIP4K2A', 'PFN1', 'PAK3', 'FGFR3', 'FGF12', 'VCL']",0.8659954209461144,0,0,17
167,ERK Pathway in Huntington's Disease WP3853,0.28312561242927636,1.777840909090909,2.243394542533216,"['EGF', 'HRAS', 'GRM1']",0.8659954209461144,0,0,3
168,NAD+ metabolism WP3644,0.28312561242927636,1.777840909090909,2.243394542533216,"['NT5E', 'NAMPT', 'CD38']",0.8659954209461144,0,0,3
169,Transcription factor regulation in adipogenesis WP3599,0.28312561242927636,1.777840909090909,2.243394542533216,"['CEBPB', 'CEBPD', 'IRS2']",0.8659954209461144,0,0,3
170,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['ELOB', 'ELOC']",0.8659954209461144,0,0,2
171,Inflammatory Response Pathway WP453,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['FN1', 'TNFRSF1A']",0.8659954209461144,0,0,2
172,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['EGF', 'FN1']",0.8659954209461144,0,0,2
173,Peptide GPCRs WP24,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['OXTR', 'EDNRA']",0.8659954209461144,0,0,2
174,RAS and bradykinin pathways in COVID-19 WP4969,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['SERPING1', 'KLKB1']",0.8659954209461144,0,0,2
175,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.28921602798772905,2.1726004580470537,2.6952876492789324,"['STAT3', 'RASGRF1']",0.8659954209461144,0,0,2
176,G13 Signaling Pathway WP524,0.29488985005557183,1.3972179980320243,1.7062174837044466,"['CFL1', 'ARHGDIG', 'PIK3CD', 'PIP4K2A', 'PAK3', 'PFN1']",0.8779675081199979,0,0,6
177,NRF2-ARE regulation WP4357,0.303095803064476,1.5338998638855166,1.8310259950785759,"['NQO1', 'CEBPB', 'MAF', 'GCLM']",0.880012122369663,0,0,4
178,Tryptophan metabolism WP465,0.303095803064476,1.5338998638855166,1.8310259950785759,"['WARS', 'MAOB', 'AADAT', 'DHCR24']",0.880012122369663,0,0,4
179,Wnt signaling in kidney disease WP4150,0.303095803064476,1.5338998638855166,1.8310259950785759,"['WNT2B', 'FZD4', 'WNT7B', 'WNT7A']",0.880012122369663,0,0,4
180,DNA damage response WP707,0.3039736529559332,1.3042006269592477,1.5530606904506965,"['CDKN1A', 'CCND3', 'CCND2', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CYCS', 'PML']",0.880012122369663,0,0,8
181,Translation Factors WP107,0.3039736529559332,1.3042006269592477,1.5530606904506965,"['EIF4A2', 'EEF1B2', 'EIF5A', 'EEF1A1', 'EEF1A2', 'EEF2', 'EIF4B', 'EIF1']",0.880012122369663,0,0,8
182,Non-small cell lung cancer WP4255,0.30748599346457167,1.254164855859771,1.4790688998312713,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'STAT3', 'PLCG2', 'PIK3CD', 'CYCS', 'HRAS', 'RXRG']",0.8852893438210745,0,0,10
183,Allograft Rejection WP2328,0.3135664676821892,1.4172607063176796,1.643659491822601,"['TUBA1B', 'HLA-B', 'PRKCZ', 'HLA-E', 'VEGFA']",0.8929827666601476,0,0,5
184,Bladder cancer WP2828,0.3135664676821892,1.4172607063176796,1.643659491822601,"['CDKN1A', 'EGF', 'HRAS', 'FGFR3', 'VEGFA']",0.8929827666601476,0,0,5
185,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3217991169803398,1.62953125,1.847607813363524,"['ACTN1', 'PRKCQ', 'VCL']",0.9017258679021287,0,0,3
186,Purinergic signaling WP4900,0.3217991169803398,1.62953125,1.847607813363524,"['P2RY12', 'P2RY14', 'GNAI1']",0.9017258679021287,0,0,3
187,Sleep regulation WP3591,0.3217991169803398,1.62953125,1.847607813363524,"['CST3', 'OXTR', 'IL18']",0.9017258679021287,0,0,3
188,IL-18 signaling pathway WP4754,0.3270640053815239,1.1249508325685067,1.257244366651109,"['CEBPB', 'NRN1', 'CD81', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'SOCS3', 'TMSB4X', 'STMN1', 'NFKBIZ', 'SPP1', 'CCL2', 'RPS11', 'B2M', 'FN1', 'IL18', 'EEF2', 'VEGFA', 'TNFRSF1A', 'ACTA2', 'KITLG', 'CYCS', 'KIFC3', 'PTPN7', 'ARF6']",0.9085925933423415,0,0,25
189,ESC Pluripotency Pathways WP3931,0.3414442669948459,1.1856465344837437,1.2740611615468886,"['SMAD1', 'WNT2B', 'FZD4', 'EGF', 'WNT7B', 'STAT3', 'SMAD9', 'PIK3CD', 'WNT7A', 'FGFR3', 'FGF12', 'HRAS']",0.9085925933423415,0,0,12
190,Common Pathways Underlying Drug Addiction WP2636,0.3443912776909055,1.3038196618659987,1.38984155376349,"['GRM5', 'CAMK2A', 'GNAI1', 'GRM1', 'ACTB', 'ACTG1']",0.9085925933423415,0,0,6
191,Notch Signaling WP268,0.3443912776909055,1.3038196618659987,1.38984155376349,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.9085925933423415,0,0,6
192,Glucocorticoid Receptor Pathway WP2880,0.3456343729016019,1.2676656920077973,1.3467348036057587,"['AKAP13', 'GADD45B', 'ENC1', 'CCL2', 'SPINK13', 'PMP2', 'ANGPTL4']",0.9085925933423415,0,0,7
193,IL-1 signaling pathway WP195,0.34579667684080345,1.2418569935811314,1.3187333011404134,"['IL1R1', 'TOLLIP', 'PELI1', 'CCL2', 'TAB2', 'IL1RAP', 'PRKCZ', 'MAP3K14']",0.9085925933423415,0,0,8
194,Benzene metabolism WP3891,0.34852502149200504,3.2581148564294633,3.434200500355241,['NQO1'],0.9085925933423415,0,0,1
195,Composition of Lipid Particles WP3601,0.34852502149200504,3.2581148564294633,3.434200500355241,['APOE'],0.9085925933423415,0,0,1
196,COVID-19 adverse outcome pathway WP4891,0.34852502149200504,3.2581148564294633,3.434200500355241,['CCL2'],0.9085925933423415,0,0,1
197,Drug Induction of Bile Acid Pathway WP2289,0.34852502149200504,3.2581148564294633,3.434200500355241,['SLC51A'],0.9085925933423415,0,0,1
198,Hypothetical Craniofacial Development Pathway WP3655,0.34852502149200504,3.2581148564294633,3.434200500355241,['ARHGAP29'],0.9085925933423415,0,0,1
199,Macrophage markers WP4146,0.34852502149200504,3.2581148564294633,3.434200500355241,['F3'],0.9085925933423415,0,0,1
200,Steroid Biosynthesis WP496,0.34852502149200504,3.2581148564294633,3.434200500355241,['HSD17B7'],0.9085925933423415,0,0,1
201,Tamoxifen metabolism WP691,0.34852502149200504,3.2581148564294633,3.434200500355241,['CYP3A5'],0.9085925933423415,0,0,1
202,Apoptosis Modulation by HSP70 WP384,0.36048696663050556,1.5040384615384614,1.534569654945845,"['CYCS', 'TNFRSF1A', 'HSPA1A']",0.9305180813516498,0,0,3
203,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.36048696663050556,1.5040384615384614,1.534569654945845,"['NQO1', 'GSTP1', 'GCLM']",0.9305180813516498,0,0,3
204,Neural Crest Differentiation WP2064,0.3650887124123348,1.1974496197475226,1.2065680875096219,"['SMAD1', 'NOTCH1', 'DCT', 'ZIC1', 'HES1', 'FGFR3', 'HES5', 'GFAP', 'RHOB']",0.9332023673368949,0,0,9
205,Proteasome Degradation WP183,0.3650887124123348,1.1974496197475226,1.2065680875096219,"['PSMD10', 'PSMB6', 'UBB', 'H2AFZ', 'NEDD4', 'HLA-B', 'PSMB10', 'HLA-E', 'PSMB9']",0.9332023673368949,0,0,9
206,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3669996779094792,1.2128599548006125,1.2157639157710158,"['MYO1E', 'CDKN1A', 'NOTCH1', 'PODXL', 'PLCE1', 'MYH9', 'SYNPO', 'VCL']",0.9335331612843063,0,0,8
207,DNA damage response (only ATM dependent) WP710,0.3752352239531455,1.1505527415240138,1.127774312102103,"['CCND3', 'CDKN1A', 'CCND2', 'SMAD3', 'WNT2B', 'BCL6', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'SOD2', 'HRAS']",0.9377181591654055,0,0,12
208,Pancreatic adenocarcinoma pathway WP4263,0.3784626010218027,1.1566805803209597,1.1238748281222148,"['CDKN1A', 'SMAD3', 'GADD45B', 'EGF', 'GADD45A', 'STAT3', 'PEBP1', 'PIK3CD', 'PAK3', 'RALGDS', 'VEGFA']",0.9377181591654055,0,0,11
209,Alzheimer's disease WP2059,0.38173097079681484,1.1641332615908888,1.1211059456303705,"['ATP5MD', 'PPP3CC', 'CYCS', 'CACNA1D', 'CALM3', 'APOE', 'GAPDH', 'TNFRSF1A', 'SNCA', 'CDK5R1']",0.9377181591654055,0,0,10
210,Fragile X Syndrome  WP4549,0.3919948578690135,1.109761492981539,1.0392989148375986,"['GABRA1', 'KCNC1', 'SHC1', 'GAD1', 'CAMK2A', 'CLTB', 'CLTA', 'AKAP5', 'GRM1', 'EEF1A1', 'GRM5', 'PRKAR1A', 'MAP1B', 'AP2S1', 'GABRD', 'SHANK1']",0.9377181591654055,0,0,16
211,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['NOTCH1', 'VEGFA']",0.9377181591654055,0,0,2
212,Eicosanoid Synthesis WP167,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['PNPLA3', 'PLA2G5']",0.9377181591654055,0,0,2
213,Ganglio Sphingolipid Metabolism WP1423,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['ST8SIA1', 'ST8SIA5']",0.9377181591654055,0,0,2
214,miRNAs involved in DNA damage response WP1545,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['CDKN1A', 'CCND3']",0.9377181591654055,0,0,2
215,Osteopontin Signaling WP1434,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['SPP1', 'MAP3K14']",0.9377181591654055,0,0,2
216,Serotonin and anxiety WP3947,0.3922571779229547,1.6291380387257963,1.5246086129717977,"['GABRA1', 'GRM1']",0.9377181591654055,0,0,2
217,Glycogen Synthesis and Degradation WP500,0.3945786620225968,1.2220961177207263,1.1364721063351673,"['GSK3A', 'HKDC1', 'PYGM', 'CALM3', 'PYGL', 'GYG2']",0.9377181591654055,0,0,6
218,One-carbon metabolism and related pathways WP3940,0.3945786620225968,1.2220961177207263,1.1364721063351673,"['AHCYL1', 'GPX4', 'GAD1', 'SOD2', 'GCLM', 'SOD1']",0.9377181591654055,0,0,6
219,Angiogenesis WP1539,0.3988200846662372,1.3964732142857144,1.283700851463635,"['SMAD1', 'TIMP2', 'VEGFA']",0.9377181591654055,0,0,3
220,Canonical and non-canonical Notch signaling WP3845,0.3988200846662372,1.3964732142857144,1.283700851463635,"['NOTCH1', 'HEY1', 'HES1']",0.9377181591654055,0,0,3
221,Oxysterols derived from cholesterol WP4545,0.39906707918680423,1.3034396497811132,1.1973732362351588,"['CYP39A1', 'DBP', 'DHCR7', 'ACOT6']",0.9377181591654055,0,0,4
222,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.39906707918680423,1.3034396497811132,1.1973732362351588,"['LDHA', 'PGK1', 'SLC2A3', 'VEGFA']",0.9377181591654055,0,0,4
223,Signal transduction through IL1R WP4496,0.39906707918680423,1.3034396497811132,1.1973732362351588,"['IL1R1', 'TOLLIP', 'IL1RAP', 'MAP3K14']",0.9377181591654055,0,0,4
224,Wnt signaling WP428,0.41428312275526535,1.1203183888190955,0.9872309136327241,"['CCND3', 'CCND2', 'WNT2B', 'PPP3CC', 'DAAM1', 'DAAM2', 'WIF1', 'WNT7B', 'CAMK2A', 'NFATC2', 'WNT7A']",0.9451340630796213,0,0,11
225,Metabolic reprogramming in colon cancer WP4290,0.41966160858759866,1.184949052200148,1.0288990664428856,"['LDHA', 'MDH2', 'PGAM1', 'FASN', 'PGK1', 'GAPDH']",0.9451340630796213,0,0,6
226,Cells and molecules involved in local acute inflammatory response  WP4493,0.43525476095163224,2.1718684977111944,1.8066118242566207,['ICAM1'],0.9451340630796213,0,0,1
227,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.43525476095163224,2.1718684977111944,1.8066118242566207,['OPLAH'],0.9451340630796213,0,0,1
228,Irinotecan pathway WP229,0.43525476095163224,2.1718684977111944,1.8066118242566207,['CYP3A5'],0.9451340630796213,0,0,1
229,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.43525476095163224,2.1718684977111944,1.8066118242566207,['CDKN1A'],0.9451340630796213,0,0,1
230,Osteoblast Signaling WP322,0.43525476095163224,2.1718684977111944,1.8066118242566207,['TNFRSF11B'],0.9451340630796213,0,0,1
231,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.43525476095163224,2.1718684977111944,1.8066118242566207,['CD247'],0.9451340630796213,0,0,1
232,The alternative pathway of fetal androgen synthesis WP4524,0.43525476095163224,2.1718684977111944,1.8066118242566207,['HSD17B6'],0.9451340630796213,0,0,1
233,Genes controlling nephrogenesis WP4823,0.4364847288128173,1.30325,1.0803967129497947,"['ROBO2', 'SLIT2', 'VEGFA']",0.9451340630796213,0,0,3
234,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4364847288128173,1.30325,1.0803967129497947,"['SHISA5', 'TNFRSF10B', 'CYS1']",0.9451340630796213,0,0,3
235,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.4364847288128173,1.30325,1.0803967129497947,"['IFNAR2', 'IRF7', 'IRF9']",0.9451340630796213,0,0,3
236,BMP Signaling Pathway in Eyelid Development WP3927,0.44126689336577357,1.447983898952044,1.1846034268914607,"['SMAD1', 'NOTCH1']",0.9451340630796213,0,0,2
237,Cancer immunotherapy by PD-1 blockade WP4585,0.44126689336577357,1.447983898952044,1.1846034268914607,"['STAT3', 'NFATC2']",0.9451340630796213,0,0,2
238,Cell Differentiation - Index expanded WP2023,0.44126689336577357,1.447983898952044,1.1846034268914607,"['ID2', 'STAT3']",0.9451340630796213,0,0,2
239,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.44126689336577357,1.447983898952044,1.1846034268914607,"['RPH3A', 'SYTL4']",0.9451340630796213,0,0,2
240,GDNF/RET signaling axis WP4830,0.44126689336577357,1.447983898952044,1.1846034268914607,"['ROBO2', 'SLIT2']",0.9451340630796213,0,0,2
241,GPR40 Pathway WP3958,0.44126689336577357,1.447983898952044,1.1846034268914607,"['PLCG2', 'PLCE1']",0.9451340630796213,0,0,2
242,RalA downstream regulated genes WP2290,0.44126689336577357,1.447983898952044,1.1846034268914607,"['YBX3', 'HRAS']",0.9451340630796213,0,0,2
243,Tryptophan catabolism leading to NAD+ production WP4210,0.44126689336577357,1.447983898952044,1.1846034268914607,"['AADAT', 'NAMPT']",0.9451340630796213,0,0,2
244,Cytosolic DNA-sensing pathway WP4655,0.444605795981433,1.1499871081807802,0.9321418776264189,"['RNF125', 'IL18', 'IRF7', 'POLR2E', 'POLR2K', 'POLR2L']",0.9451340630796213,0,0,6
245,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.444605795981433,1.1499871081807802,0.9321418776264189,"['EIF4A2', 'RPS6KA2', 'RPS6', 'PIM1', 'PDCD4', 'EIF4B']",0.9451340630796213,0,0,6
246,Metapathway biotransformation Phase I and II WP702,0.450131395755365,1.0861599664991626,0.8669899904013975,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'GPX4', 'GSTP1', 'MGST1', 'KCNAB1', 'SULT4A1', 'CYP3A5', 'HS6ST3']",0.9451340630796213,0,0,11
247,TGF-beta Signaling Pathway WP366,0.45687408335636287,1.062554758514949,0.8323495656828169,"['KLF10', 'CDKN1A', 'SMAD3', 'SHC1', 'LIMK2', 'FN1', 'NEDD4L', 'PML', 'PJA1', 'EID2', 'KLF6', 'PARD6A', 'SUMO1', 'JUNB', 'SKP1']",0.9451340630796213,0,0,15
248,Pathways in clear cell renal cell carcinoma WP4018,0.45716736619672005,1.0861058798911907,0.8501012924619914,"['LDHA', 'TPI1', 'MDH1', 'FASN', 'STAT3', 'PGK1', 'ENPP3', 'RAPGEF5', 'GAPDH', 'VEGFA']",0.9451340630796213,0,0,10
249,Small cell lung cancer WP4658,0.45716736619672005,1.0861058798911907,0.8501012924619914,"['CDKN1A', 'GADD45B', 'COL4A1', 'GADD45A', 'LAMA3', 'FN1', 'PIK3CD', 'CYCS', 'RXRG', 'SKP1']",0.9451340630796213,0,0,10
250,Kit receptor signaling pathway WP304,0.4602496007153904,1.1125374411638853,0.8633138419599626,"['KITLG', 'SHC1', 'RPS6', 'STAT3', 'GAB2', 'JUNB', 'HRAS']",0.9451340630796213,0,0,7
251,Modulators of TCR signaling and T cell activation WP5072,0.46932081058977876,1.1170229895339476,0.8449929435860164,"['NDUFB10', 'ELOB', 'PRKCQ', 'RNF7', 'CD247', 'MAP3K14']",0.9451340630796213,0,0,6
252,Cannabinoid receptor signaling WP3869,0.4732199706080119,1.2216796875,0.9140545659306266,"['PRKAR2B', 'PRKAR1A', 'AHR']",0.9451340630796213,0,0,3
253,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4732199706080119,1.2216796875,0.9140545659306266,"['LDHA', 'RPS6', 'VEGFA']",0.9451340630796213,0,0,3
254,Immune response to tuberculosis WP4197,0.4732199706080119,1.2216796875,0.9140545659306266,"['IFNAR2', 'IFI35', 'IRF9']",0.9451340630796213,0,0,3
255,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4732199706080119,1.2216796875,0.9140545659306266,"['MDH1', 'MDH2', 'NAMPT']",0.9451340630796213,0,0,3
256,PKC-gamma calcium signaling pathway in ataxia WP4760,0.4732199706080119,1.2216796875,0.9140545659306266,"['GNA14', 'CACNA1A', 'GRM1']",0.9451340630796213,0,0,3
257,Pre-implantation embryo WP3527,0.4732199706080119,1.2216796875,0.9140545659306266,"['ZFP36', 'ATP1A1', 'HNRNPAB']",0.9451340630796213,0,0,3
258,Prostaglandin Synthesis and Regulation WP98,0.4732199706080119,1.2216796875,0.9140545659306266,"['HSD11B1', 'EDNRA', 'S100A6']",0.9451340630796213,0,0,3
259,White fat cell differentiation WP4149,0.4732199706080119,1.2216796875,0.9140545659306266,"['SREBF1', 'CEBPB', 'CEBPD']",0.9451340630796213,0,0,3
260,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.4732199706080119,1.2216796875,0.9140545659306266,"['WIF1', 'ZBTB16', 'PML']",0.9451340630796213,0,0,3
261,MECP2 and Associated Rett Syndrome WP3584,0.47332054919779515,1.0859979101358412,0.8123073516245508,"['RBFOX1', 'CEBPD', 'BCL6', 'GAD1', 'RPS6', 'CAMK2A', 'IGF1R', 'FKBP5']",0.9451340630796213,0,0,8
262,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4798422713852113,1.123386992361141,0.8249006311479496,"['ACTA2', 'PAK3', 'ACTB', 'ACTG1', 'TEAD3']",0.9451340630796213,0,0,5
263,Nephrotic syndrome WP4758,0.4798422713852113,1.123386992361141,0.8249006311479496,"['MYO1E', 'PODXL', 'PLCE1', 'MYH9', 'SYNPO']",0.9451340630796213,0,0,5
264,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.4880047198095566,1.3030605871330418,0.9348550195086931,"['STAT3', 'CCL2']",0.9451340630796213,0,0,2
265,Lipid Metabolism Pathway WP3965,0.49253026770864966,1.1330994915300323,0.8024603380967613,"['PRKAR2B', 'PRKAR1A', 'FASN', 'HILPDA']",0.9451340630796213,0,0,4
266,Neural Crest Cell Migration during Development WP4564,0.49253026770864966,1.1330994915300323,0.8024603380967613,"['STAT3', 'PIK3CD', 'PAK3', 'EPHB1']",0.9451340630796213,0,0,4
267,G1 to S cell cycle control WP45,0.49372341813788684,1.085890210811939,0.76639937678482,"['CDKN2D', 'CDKN1A', 'CCND3', 'CCND2', 'GADD45A', 'RPA3']",0.9451340630796213,0,0,6
268,PPAR signaling pathway WP3942,0.49372341813788684,1.085890210811939,0.76639937678482,"['FABP3', 'FABP5', 'SCD', 'DBI', 'ANGPTL4', 'RXRG']",0.9451340630796213,0,0,6
269,Melanoma WP4685,0.4942270589066869,1.063732326786514,0.7496762435170362,"['GRM3', 'CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'CALM3', 'HRAS', 'VCL']",0.9451340630796213,0,0,8
270,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.4944638645009593,1.0205056115393725,0.718722922223209,"['CDKN1A', 'LAMA3', 'PIK3CD', 'IRS2', 'SLC2A3', 'IGF1R', 'GNG3', 'GNG2', 'SPP1', 'HRAS', 'EIF4B', 'IFNAR2', 'SREBF1', 'EGF', 'HGF', 'RPS6', 'FN1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A1', 'CDC37', 'FGFR3', 'FGF12', 'EPHA2']",0.9451340630796213,0,0,26
271,AGE/RAGE pathway WP2324,0.505138104070495,1.0605875152998776,0.7243000464622918,"['LGALS3', 'SMAD3', 'SHC1', 'STAT3', 'CYCS', 'PRKCZ', 'SOD1']",0.9451340630796213,0,0,7
272,Cell migration and invasion through p75NTR WP4561,0.5088141139469483,1.1497058823529411,0.7768246796011405,"['EFNA1', 'PARD3', 'STAT3']",0.9451340630796213,0,0,3
273,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5088141139469483,1.1497058823529411,0.7768246796011405,"['SMAD3', 'HGF', 'HRAS']",0.9451340630796213,0,0,3
274,Unfolded protein response WP4925,0.5088141139469483,1.1497058823529411,0.7768246796011405,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.9451340630796213,0,0,3
275,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5104445417013985,1.62874531835206,1.0952877106464785,['HSD11B1'],0.9451340630796213,0,0,1
276,Estrogen metabolism WP697,0.5104445417013985,1.62874531835206,1.0952877106464785,['NQO1'],0.9451340630796213,0,0,1
277,FOXP3 in COVID-19 WP5063,0.5104445417013985,1.62874531835206,1.0952877106464785,['STAT3'],0.9451340630796213,0,0,1
278,Role of Osx and miRNAs in tooth development WP3971,0.5104445417013985,1.62874531835206,1.0952877106464785,['NOTCH1'],0.9451340630796213,0,0,1
279,SARS-CoV-2 and COVID-19 Pathway WP4846,0.5104445417013985,1.62874531835206,1.0952877106464785,['NRP1'],0.9451340630796213,0,0,1
280,Serotonin Transporter Activity WP1455,0.5104445417013985,1.62874531835206,1.0952877106464785,['IL1R1'],0.9451340630796213,0,0,1
281,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.5104445417013985,1.62874531835206,1.0952877106464785,['IGF1R'],0.9451340630796213,0,0,1
282,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.5104445417013985,1.62874531835206,1.0952877106464785,['STAT3'],0.9451340630796213,0,0,1
283,Vitamin D Metabolism WP1531,0.5104445417013985,1.62874531835206,1.0952877106464785,['DHCR7'],0.9451340630796213,0,0,1
284,Alpha 6 Beta 4 signaling pathway WP244,0.5223575523901672,1.085782780904732,0.7051105510951193,"['SHC1', 'LAMA3', 'IRS2', 'HRAS']",0.9576180494213457,0,0,4
285,Airway smooth muscle cell contraction WP4962,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['PPP1R14A', 'CD38']",0.9576180494213457,0,0,2
286,Canonical and non-canonical TGF-B signaling WP3874,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['SMAD3', 'LOXL2']",0.9576180494213457,0,0,2
287,miRNA targets in ECM and membrane receptors WP2911,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['COL4A1', 'FN1']",0.9576180494213457,0,0,2
288,Omega-9 FA synthesis WP4724,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['SCD', 'FASN']",0.9576180494213457,0,0,2
289,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['LDHA', 'SLC2A3']",0.9576180494213457,0,0,2
290,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5322070505774176,1.1844869683720403,0.7470827862824017,"['SMAD3', 'FN1']",0.9576180494213457,0,0,2
291,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5327233929239867,1.05070854697404,0.6616868092989538,"['IFNAR2', 'SMAD3', 'CXCL17', 'IRF7', 'CCL2']",0.9576180494213457,0,0,5
292,Head and Neck Squamous Cell Carcinoma WP4674,0.535260351137523,1.0218206404818981,0.6386399570377083,"['FKBP1A', 'CDKN1A', 'NOTCH1', 'RPS6', 'HRAS', 'FGFR3', 'IGF1R', 'VEGFA']",0.9576180494213457,0,0,8
293,EPO Receptor Signaling WP581,0.5431004794361484,1.0857291666666666,0.6627952380761172,"['SHC1', 'STAT3', 'IRS2']",0.9576180494213457,0,0,3
294,miRNAs involvement in the immune response in sepsis WP4329,0.5431004794361484,1.0857291666666666,0.6627952380761172,"['IRF7', 'TAB2', 'ICAM1']",0.9576180494213457,0,0,3
295,Trans-sulfuration and one-carbon metabolism WP2525,0.5431004794361484,1.0857291666666666,0.6627952380761172,"['DHFR', 'AHCYL1', 'GCLM']",0.9576180494213457,0,0,3
296,Chemokine signaling pathway WP3929,0.5503452455771648,0.9961376248612652,0.5949028314155083,"['SHC1', 'STAT3', 'PIK3CD', 'PRKX', 'ADCY2', 'CXCL14', 'PRKCZ', 'GNAI1', 'GNG3', 'GNG2', 'GRK5', 'PARD3', 'HRAS']",0.9576180494213457,0,0,13
297,Interleukin-11 Signaling Pathway WP2332,0.5582342029251343,1.01777612640801,0.5933397534201733,"['SOCS3', 'STAT3', 'RPS6', 'HRAS', 'ICAM1']",0.9576180494213457,0,0,5
298,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5643371494337751,1.0020711911757623,0.573288358963147,"['CCND3', 'WNT2B', 'CCND2', 'WIF1', 'WNT7B', 'WNT7A']",0.9576180494213457,0,0,6
299,MET in type 1 papillary renal cell carcinoma WP4205,0.5698669897978837,0.9911327231121282,0.5573657630933347,"['CDKN1A', 'HGF', 'RPL11', 'STAT3', 'PIK3CD', 'PAK3', 'HRAS']",0.9576180494213457,0,0,7
300,SARS coronavirus and innate immunity WP4912,0.5737205960339025,1.085675619404539,0.6032152356819207,"['IFNAR2', 'IRF9']",0.9576180494213457,0,0,2
301,Aspirin and miRNAs WP4707,0.5756289973790899,1.3028714107365793,0.7195653628263005,['VEGFA'],0.9576180494213457,0,0,1
302,Biogenic Amine Synthesis WP550,0.5756289973790899,1.3028714107365793,0.7195653628263005,['GAD1'],0.9576180494213457,0,0,1
303,Caloric restriction and aging WP4191,0.5756289973790899,1.3028714107365793,0.7195653628263005,['NAMPT'],0.9576180494213457,0,0,1
304,Disorders of Folate Metabolism and Transport WP4259,0.5756289973790899,1.3028714107365793,0.7195653628263005,['DHFR'],0.9576180494213457,0,0,1
305,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5756289973790899,1.3028714107365793,0.7195653628263005,['CEBPB'],0.9576180494213457,0,0,1
306,Genes targeted by miRNAs in adipocytes WP1992,0.5756289973790899,1.3028714107365793,0.7195653628263005,['TMSB4X'],0.9576180494213457,0,0,1
307,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5756289973790899,1.3028714107365793,0.7195653628263005,['RPS6'],0.9576180494213457,0,0,1
308,Insulin signaling in adipocytes (normal condition) WP3634,0.5756289973790899,1.3028714107365793,0.7195653628263005,['RPS6'],0.9576180494213457,0,0,1
309,LDLRAD4 and what we know about it WP4904,0.5756289973790899,1.3028714107365793,0.7195653628263005,['NEDD4'],0.9576180494213457,0,0,1
310,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5756289973790899,1.3028714107365793,0.7195653628263005,['APOE'],0.9576180494213457,0,0,1
311,miRNA Biogenesis WP2338,0.5756289973790899,1.3028714107365793,0.7195653628263005,['RAN'],0.9576180494213457,0,0,1
312,Monoamine GPCRs WP58,0.5756289973790899,1.3028714107365793,0.7195653628263005,['CHRM3'],0.9576180494213457,0,0,1
313,Sulfation Biotransformation Reaction WP692,0.5756289973790899,1.3028714107365793,0.7195653628263005,['SULT4A1'],0.9576180494213457,0,0,1
314,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5759528723222601,1.028486842105263,0.5674464699754358,"['RAB13', 'NDRG1', 'TEAD3']",0.9576180494213457,0,0,3
315,DNA Replication WP466,0.5793223695926843,1.0020686005676624,0.5470254279195059,"['POLD4', 'RPA3', 'CDC7', 'UBA52']",0.9576180494213457,0,0,4
316,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5793223695926843,1.0020686005676624,0.5470254279195059,"['MAP1LC3A', 'SMAD3', 'IGF1R', 'TNFRSF1A']",0.9576180494213457,0,0,4
317,Neural Crest Cell Migration in Cancer WP4565,0.5793223695926843,1.0020686005676624,0.5470254279195059,"['STAT3', 'PIK3CD', 'PAK3', 'EPHB1']",0.9576180494213457,0,0,4
318,Androgen receptor signaling pathway WP138,0.5841810015264519,0.9719762768080501,0.5224804143022277,"['CDKN1A', 'SMAD3', 'SUMO1', 'LIMK2', 'BAG1', 'STAT3', 'DSTN', 'STUB1', 'RAN', 'RHOB']",0.957759383472874,0,0,10
319,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5868085276030779,0.9769254852849092,0.5207566757564973,"['IL1R1', 'TOLLIP', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14']",0.957759383472874,0,0,6
320,MAPK Signaling Pathway WP382,0.587127082631613,0.9705018114303022,0.5168057894537875,"['IL1R1', 'GADD45A', 'EGF', 'RASGRF1', 'CACNA1B', 'CACNA1A', 'HSPB1', 'CACNA1D', 'MAPK8IP2', 'MAPK8IP1', 'TNFRSF1A', 'PPP3CC', 'MRAS', 'STMN1', 'TAB2', 'PTPN7', 'MAP3K6', 'CACNG2', 'HRAS', 'FGFR3', 'FGF12', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.957759383472874,0,0,24
321,PI3K-Akt signaling pathway WP4172,0.59080096101717,0.9687707465749291,0.509840891937974,"['CDKN1A', 'LAMA3', 'PIK3CD', 'IGF1R', 'CCND3', 'GNG3', 'CCND2', 'GNG2', 'SPP1', 'HRAS', 'EIF4B', 'IFNAR2', 'EGF', 'HGF', 'RPS6', 'FN1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A1', 'CDC37', 'FGFR3', 'FGF12', 'EPHA2']",0.957759383472874,0,0,25
322,B Cell Receptor Signaling Pathway WP23,0.5977938512058344,0.9607750375383096,0.4943277063269843,"['GSK3A', 'BCL6', 'CD81', 'SHC1', 'CAMK2A', 'PLCG2', 'NFATC2', 'GAB2', 'HRAS']",0.957759383472874,0,0,9
323,Wnt signaling pathway and pluripotency WP399,0.5977938512058344,0.9607750375383096,0.4943277063269843,"['CCND3', 'CCND2', 'WNT2B', 'FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'PRKCZ', 'CD44']",0.957759383472874,0,0,9
324,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6062963724690787,0.9648622981956315,0.4828039226674472,"['HEXIM1', 'PPP3CC', 'SUPT4H1', 'NFATC2']",0.957759383472874,0,0,4
325,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6072809686862006,0.97696875,0.48727656236048816,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.957759383472874,0,0,3
326,MAPK pathway in congenital thyroid cancer WP4928,0.6124777171185986,1.0020660164320376,0.49125556694948097,"['GAREM2', 'SHC1']",0.957759383472874,0,0,2
327,Overview of interferons-mediated signaling pathway WP4558,0.6124777171185986,1.0020660164320376,0.49125556694948097,"['IFNAR2', 'IRF9']",0.957759383472874,0,0,2
328,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.6321387903705978,1.0856221389929255,0.4979165815116916,['APOE'],0.957759383472874,0,0,1
329,Cell Differentiation - Index WP2029,0.6321387903705978,1.0856221389929255,0.4979165815116916,['STAT3'],0.957759383472874,0,0,1
330,"Cerebral organic acidurias, including diseases WP4519",0.6321387903705978,1.0856221389929255,0.4979165815116916,['MDH2'],0.957759383472874,0,0,1
331,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6321387903705978,1.0856221389929255,0.4979165815116916,['STAT3'],0.957759383472874,0,0,1
332,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.6321387903705978,1.0856221389929255,0.4979165815116916,['PRKCZ'],0.957759383472874,0,0,1
333,Serine Metabolism WP4688,0.6321387903705978,1.0856221389929255,0.4979165815116916,['DHFR'],0.957759383472874,0,0,1
334,Type III interferon signaling WP2113,0.6321387903705978,1.0856221389929255,0.4979165815116916,['IRF9'],0.957759383472874,0,0,1
335,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6321853635351531,0.9303135888501742,0.42661635019224425,"['IFITM3', 'IFITM2', 'RPS6KA2', 'JUNB']",0.957759383472874,0,0,4
336,IL-5 signaling pathway WP127,0.6321853635351531,0.9303135888501742,0.42661635019224425,"['GSK3A', 'SHC1', 'STAT3', 'RPS6']",0.957759383472874,0,0,4
337,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6321853635351531,0.9303135888501742,0.42661635019224425,"['ACTN2', 'CAMK2A', 'NEFL', 'CYCS']",0.957759383472874,0,0,4
338,p38 MAPK Signaling Pathway WP400,0.6321853635351531,0.9303135888501742,0.42661635019224425,"['SHC1', 'RASGRF1', 'HSPB1', 'HRAS']",0.957759383472874,0,0,4
339,Parkinson's disease pathway WP2371,0.6321853635351531,0.9303135888501742,0.42661635019224425,"['PINK1', 'UBB', 'CYCS', 'SNCA']",0.957759383472874,0,0,4
340,16p11.2 distal deletion syndrome WP4950,0.6370257862477454,0.9303571428571429,0.41954003525810524,"['PLN', 'CD81', 'NFATC2']",0.957759383472874,0,0,3
341,Nanoparticle-mediated activation of receptor signaling WP2643,0.6370257862477454,0.9303571428571429,0.41954003525810524,"['FN1', 'PIK3CD', 'HRAS']",0.957759383472874,0,0,3
342,Microglia Pathogen Phagocytosis Pathway WP3937,0.6484763645261071,0.930400642455608,0.4029841718613884,"['PLCG2', 'PIK3CD']",0.957759383472874,0,0,2
343,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6484763645261071,0.930400642455608,0.4029841718613884,"['MOG', 'PLP1']",0.957759383472874,0,0,2
344,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6484763645261071,0.930400642455608,0.4029841718613884,"['PIK3CD', 'HRAS']",0.957759383472874,0,0,2
345,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6484763645261071,0.930400642455608,0.4029841718613884,"['RASGRF1', 'HRAS']",0.957759383472874,0,0,2
346,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.652615329495834,0.9043422333472396,0.3859437883551734,"['PPP1R3G', 'PPP1R14A', 'XBP1', 'MAP1LC3A', 'PPP1R3C']",0.957759383472874,0,0,5
347,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.652615329495834,0.9043422333472396,0.3859437883551734,"['SMAD3', 'CFL1', 'ADCY2', 'HRAS', 'SYNE2']",0.957759383472874,0,0,5
348,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6569497523923927,0.8981475491147485,0.3773546663593206,"['HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.957759383472874,0,0,4
349,Phosphoinositides metabolism WP4971,0.6569497523923927,0.8981475491147485,0.3773546663593206,"['PLCG2', 'PIK3CD', 'PIP4K2A', 'PLCE1']",0.957759383472874,0,0,4
350,BDNF-TrkB Signaling WP3676,0.6651553552669653,0.8879829545454545,0.36206141799446745,"['SHC1', 'GAB2', 'HRAS']",0.957759383472874,0,0,3
351,Resistin as a regulator of inflammation WP4481,0.6651553552669653,0.8879829545454545,0.36206141799446745,"['PLCG2', 'PIK3CD', 'PLCE1']",0.957759383472874,0,0,3
352,7q11.23 copy number variation syndrome WP4932,0.6660064022123042,0.9040419892585617,0.3674532867690254,"['SNAP25', 'ATP5F1B', 'CFL1', 'ATP5PO', 'ATP5MC3', 'NRG1', 'GAPDH', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.957759383472874,0,0,10
353,22q11.2 copy number variation syndrome WP4657,0.6660507866088835,0.9013029630344561,0.36627992996904185,"['RTN4R', 'ACTA2', 'SREBF1', 'RANBP1', 'AIFM3', 'MRPL40', 'THAP7', 'HES1', 'RAN']",0.957759383472874,0,0,9
354,Endometrial cancer WP4155,0.667877221011958,0.8935328517371861,0.3606753605304404,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'HRAS', 'FGFR3']",0.957759383472874,0,0,7
355,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6701894194611684,0.8877725280355212,0.3552820300366764,"['PTPRT', 'IFNAR2', 'SOCS3', 'STMN1', 'STAT3', 'OSMR']",0.957759383472874,0,0,6
356,Nucleotide Excision Repair WP4753,0.6740871911596836,0.879815986198965,0.3469957409018037,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLE3']",0.957759383472874,0,0,5
357,Autosomal recessive Osteopetrosis pathways WP4788,0.6811277073694275,0.9304440877474586,0.3572956110708733,['SNX10'],0.957759383472874,0,0,1
358,Cancer immunotherapy by CTLA4 blockade WP4582,0.6811277073694275,0.9304440877474586,0.3572956110708733,['PIK3CD'],0.957759383472874,0,0,1
359,Estrogen Receptor Pathway WP2881,0.6811277073694275,0.9304440877474586,0.3572956110708733,['STAT3'],0.957759383472874,0,0,1
360,Iron metabolism in placenta WP2007,0.6811277073694275,0.9304440877474586,0.3572956110708733,['FTH1'],0.957759383472874,0,0,1
361,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6811277073694275,0.9304440877474586,0.3572956110708733,['ADCY2'],0.957759383472874,0,0,1
362,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6811277073694275,0.9304440877474586,0.3572956110708733,['ANAPC11'],0.957759383472874,0,0,1
363,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6811277073694275,0.9304440877474586,0.3572956110708733,['CCND2'],0.957759383472874,0,0,1
364,Trans-sulfuration pathway WP2333,0.6811277073694275,0.9304440877474586,0.3572956110708733,['GCLM'],0.957759383472874,0,0,1
365,Gastric Cancer Network 1 WP2361,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['NOTCH1', 'GATD3A']",0.957759383472874,0,0,2
366,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['SMAD3', 'SHC1']",0.957759383472874,0,0,2
367,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['MRAS', 'HRAS']",0.957759383472874,0,0,2
368,Kallmann's Syndrome WP5074,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['SEMA3E', 'PRKCQ']",0.957759383472874,0,0,2
369,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['UGCG', 'GALNT16']",0.957759383472874,0,0,2
370,Monoamine Transport WP727,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['IL1R1', 'TNFRSF11B']",0.957759383472874,0,0,2
371,NAD+ biosynthetic pathways WP3645,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['NAMPT', 'CD38']",0.957759383472874,0,0,2
372,One-carbon metabolism WP241,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['DHFR', 'GLRX']",0.957759383472874,0,0,2
373,Purine metabolism and related disorders WP4224,0.6817638359453855,0.8682906516760358,0.33261780414288983,"['GRM5', 'HPRT1']",0.957759383472874,0,0,2
374,T-cell receptor (TCR) signaling pathway WP69,0.6857294770947345,0.8762651821862348,0.33059038554063286,"['SHC1', 'NFATC2', 'PRKCQ', 'GAB2', 'CD247', 'HRAS', 'MAP3K14']",0.9607546684428901,0,0,7
375,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6916606662510039,0.8492934782608695,0.31310037260407053,"['PIK3CD', 'PRKCQ', 'HRAS']",0.9664805043080694,0,0,3
376,Glioblastoma signaling pathways WP2261,0.699720480116712,0.8677951933124347,0.30986739400225055,"['CDKN1A', 'CCND2', 'PLCG2', 'PIK3CD', 'PRKCQ', 'HRAS', 'PRKCZ', 'IGF1R']",0.9718549812365417,0,0,8
377,Circadian rhythm related genes WP3594,0.7065625369067711,0.8871364781314404,0.30814114631306583,"['KLF10', 'SREBF1', 'KCNH7', 'AHR', 'PML', 'CST3', 'DBP', 'NFIL3', 'ID2', 'NOCT', 'NAMPT', 'ID3', 'RPS27A', 'UBA52', 'SKP1']",0.9718549812365417,0,0,15
378,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7124236906144777,0.81394440974391,0.27599428372060447,"['SREBF1', 'H3F3B']",0.9718549812365417,0,0,2
379,Gastric Cancer Network 2 WP2363,0.7124236906144777,0.81394440974391,0.27599428372060447,"['S100A6', 'CACYBP']",0.9718549812365417,0,0,2
380,Urea cycle and associated pathways WP4595,0.7124236906144777,0.81394440974391,0.27599428372060447,"['MDH1', 'MDH2']",0.9718549812365417,0,0,2
381,Zinc homeostasis WP3529,0.7124236906144777,0.81394440974391,0.27599428372060447,"['SLC39A11', 'SLC39A14']",0.9718549812365417,0,0,2
382,Base Excision Repair WP4752,0.7165519394028569,0.813828125,0.27125261201415696,"['POLE4', 'POLD4', 'POLE3']",0.9718549812365417,0,0,3
383,Vitamin D-sensitive calcium signaling in depression WP4698,0.7165519394028569,0.813828125,0.27125261201415696,"['GRM5', 'GPX4', 'SLC8A1']",0.9718549812365417,0,0,3
384,15q13.3 copy number variation syndrome WP4942,0.7235961569834731,0.8140605493133583,0.2633663638898289,['CHRNA7'],0.9718549812365417,0,0,1
385,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.7235961569834731,0.8140605493133583,0.2633663638898289,['PRKCQ'],0.9718549812365417,0,0,1
386,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7235961569834731,0.8140605493133583,0.2633663638898289,['PRKCQ'],0.9718549812365417,0,0,1
387,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7235961569834731,0.8140605493133583,0.2633663638898289,['STAT3'],0.9718549812365417,0,0,1
388,NLR Proteins WP288,0.7235961569834731,0.8140605493133583,0.2633663638898289,['ERBIN'],0.9718549812365417,0,0,1
389,IL-6 signaling pathway WP364,0.7243018572672628,0.8137116948092558,0.2624603014712425,"['SOCS3', 'SHC1', 'STAT3', 'JUNB']",0.9718549812365417,0,0,4
390,AMP-activated protein kinase (AMPK) signaling WP1403,0.7251827190300864,0.8308663851103798,0.26698364953425574,"['SREBF1', 'CDKN1A', 'FASN', 'PIK3CD', 'HMGCR', 'EEF2']",0.9718549812365417,0,0,6
391,Hippo-Yap signaling pathway WP4537,0.7405652700429384,0.7659918433332109,0.23005914377529904,"['NDRG1', 'TEAD3']",0.9718549812365417,0,0,2
392,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7405652700429384,0.7659918433332109,0.23005914377529904,"['GSK3A', 'NFATC2']",0.9718549812365417,0,0,2
393,Apoptosis WP254,0.7420114874841552,0.8134783969943644,0.24273426966822031,"['IRF7', 'TNFRSF10B', 'CYCS', 'BCL2L2', 'IGF1R', 'TNFRSF1A']",0.9718549812365417,0,0,6
394,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7420114874841552,0.8134783969943644,0.24273426966822031,"['CCND3', 'WNT2B', 'CCND2', 'WIF1', 'WNT7B', 'WNT7A']",0.9718549812365417,0,0,6
395,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7508065043368,0.8133615288220551,0.23311536072705905,"['CDKN1A', 'SMAD3', 'GADD45B', 'DCC', 'GADD45A', 'CYCS', 'RALGDS']",0.9718549812365417,0,0,7
396,Integrated breast cancer pathway WP1984,0.7529385565659396,0.8509201696241097,0.24146702284792154,"['BARD1', 'SMAD1', 'PLK3', 'GSK3A', 'GADD45A', 'AHR', 'HMGCR', 'JAKMIP1', 'PML', 'FOSL2', 'VEGFA', 'ITPKC', 'RASGEF1A', 'FAU']",0.9718549812365417,0,0,14
397,ErbB signaling pathway WP673,0.7545044703114188,0.8246593740611802,0.23230166032967697,"['CDKN1A', 'SHC1', 'EGF', 'CAMK2A', 'PLCG2', 'PIK3CD', 'NRG1', 'PAK3', 'HRAS']",0.9718549812365417,0,0,9
398,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7604115481094648,0.7235400194201692,0.19817434207263718,['SMAD1'],0.9718549812365417,0,0,1
399,Dopaminergic Neurogenesis WP2855,0.7604115481094648,0.7235400194201692,0.19817434207263718,['STAT3'],0.9718549812365417,0,0,1
400,Homologous recombination WP186,0.7604115481094648,0.7235400194201692,0.19817434207263718,['POLD4'],0.9718549812365417,0,0,1
401,"NAD metabolism, sirtuins and aging WP3630",0.7604115481094648,0.7235400194201692,0.19817434207263718,['NAMPT'],0.9718549812365417,0,0,1
402,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7604115481094648,0.7235400194201692,0.19817434207263718,['SAMHD1'],0.9718549812365417,0,0,1
403,Purine metabolism WP4792,0.7604115481094648,0.7235400194201692,0.19817434207263718,['HPRT1'],0.9718549812365417,0,0,1
404,TCA cycle in senescence WP5050,0.7604115481094648,0.7235400194201692,0.19817434207263718,['MDH1'],0.9718549812365417,0,0,1
405,Insulin Signaling WP481,0.7605340046561959,0.8527482516760152,0.2334265776949572,"['SNAP25', 'XBP1', 'GSK3A', 'SHC1', 'PIK3CD', 'IRS2', 'PRKCZ', 'IGF1R', 'SOCS3', 'RPS6KA2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'HRAS', 'VAMP2', 'ARF6']",0.9718549812365417,0,0,16
406,Development of ureteric collection system WP5053,0.7616094363603696,0.7510817307692308,0.20453563249535606,"['ROBO2', 'SMAD1', 'SLIT2']",0.9718549812365417,0,0,3
407,PDGFR-beta pathway WP3972,0.7616094363603696,0.7510817307692308,0.20453563249535606,"['SHC1', 'STAT3', 'HRAS']",0.9718549812365417,0,0,3
408,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7616094363603696,0.7510817307692308,0.20453563249535606,"['STAT3', 'RPS6', 'GAB2']",0.9718549812365417,0,0,3
409,Phosphodiesterases in neuronal function WP4222,0.7634195484256059,0.7656991502041717,0.20669859580931085,"['CHRNA7', 'PDE5A', 'ADCY2', 'PDE8B']",0.9718549812365417,0,0,4
410,Endothelin Pathways WP2197,0.7663153629859738,0.7233673398570338,0.1925325311211687,"['EDNRA', 'GNAI1']",0.9718549812365417,0,0,2
411,Fatty Acid Biosynthesis WP357,0.7663153629859738,0.7233673398570338,0.1925325311211687,"['SCD', 'FASN']",0.9718549812365417,0,0,2
412,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7663153629859738,0.7233673398570338,0.1925325311211687,"['CDKN1A', 'FGFR3']",0.9718549812365417,0,0,2
413,Toll-like Receptor Signaling related to MyD88 WP3858,0.7663153629859738,0.7233673398570338,0.1925325311211687,"['TOLLIP', 'IRF7']",0.9718549812365417,0,0,2
414,Cardiac Hypertrophic Response WP2795,0.7678396225800157,0.7747034984206449,0.20465682599084864,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A']",0.9718549812365417,0,0,5
415,Toll-like Receptor Signaling Pathway WP75,0.7734150790776302,0.7807889793362555,0.20061545412009654,"['IFNAR2', 'TOLLIP', 'IRF7', 'SPP1', 'PIK3CD', 'TAB2']",0.9765530155100679,0,0,6
416,Regulation of Microtubule Cytoskeleton WP2038,0.7812897242523628,0.7437505583847047,0.18356450424924434,"['PARD6A', 'MAP1B', 'STMN1', 'STAT3']",0.9822113463010769,0,0,4
417,Photodynamic therapy-induced unfolded protein response WP3613,0.7898116304929135,0.6852296262204544,0.1616873337790878,"['XBP1', 'WARS']",0.9822113463010769,0,0,2
418,SARS-CoV-2 mitochondrial interactions WP5038,0.7898116304929135,0.6852296262204544,0.1616873337790878,"['NDUFB9', 'IRF7']",0.9822113463010769,0,0,2
419,TLR4 Signaling and Tolerance WP3851,0.7898116304929135,0.6852296262204544,0.1616873337790878,"['IRF7', 'TAB2']",0.9822113463010769,0,0,2
420,Alanine and aspartate metabolism WP106,0.7923259620960762,0.6511235955056179,0.1515701155605315,['GAD1'],0.9822113463010769,0,0,1
421,Biomarkers for pyrimidine metabolism disorders WP4584,0.7923259620960762,0.6511235955056179,0.1515701155605315,['NT5C'],0.9822113463010769,0,0,1
422,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7923259620960762,0.6511235955056179,0.1515701155605315,['MAP3K14'],0.9822113463010769,0,0,1
423,Leptin signaling pathway WP2034,0.7928919837506785,0.7717811477847161,0.17910592257138683,"['SOCS3', 'GSK3A', 'SHC1', 'RPS6', 'STAT3', 'PLCG2', 'HRAS']",0.9822113463010769,0,0,7
424,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8006742638739662,0.6972991071428571,0.15501034212783668,"['HGF', 'STAT3', 'HRAS']",0.9895125336555621,0,0,3
425,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8102566682489883,0.7960338126451083,0.16748886319688716,"['SREBF1', 'GSK3A', 'SHC1', 'SCD', 'RPS6KA2', 'FASN', 'TRIP10', 'PIK3CD', 'IRS2', 'MAP3K6', 'MAP3K14', 'HRAS']",0.9946192923816237,0,0,12
426,Oxidation by Cytochrome P450 WP43,0.8111974697956408,0.6509056839475328,0.13619795612419053,"['CYP39A1', 'CYP3A5']",0.9946192923816237,0,0,2
427,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8111974697956408,0.6509056839475328,0.13619795612419053,"['P4HA2', 'TNFRSF11B']",0.9946192923816237,0,0,2
428,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8137953792982232,0.7034126058516302,0.1449355798364742,"['MAP1LC3A', 'GTPBP2', 'CP', 'FTL']",0.9946192923816237,0,0,4
429,Corticotropin-releasing hormone signaling pathway WP2355,0.8178194403800066,0.7463330457290768,0.1500978000918801,"['CAMK2A', 'IL18', 'PLCG2', 'PRKCQ', 'JUNB', 'GNAI1', 'FOSL2']",0.9946192923816237,0,0,7
430,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8181041207970108,0.6731896551724138,0.13515336774283757,"['CDKN1A', 'JUNB', 'TNFRSF1A']",0.9946192923816237,0,0,3
431,Cysteine and methionine catabolism WP4504,0.8199914776886669,0.5918737941209852,0.11746406146270977,['SQOR'],0.9946192923816237,0,0,1
432,Pyrimidine metabolism and related diseases WP4225,0.8199914776886669,0.5918737941209852,0.11746406146270977,['NT5C'],0.9946192923816237,0,0,1
433,Gastrin signaling pathway WP4659,0.8251936082016238,0.7599602405123108,0.1460166658361026,"['CDKN1A', 'SHC1', 'RPS6', 'STAT3', 'PRKCQ', 'HRAS', 'CD44', 'RHOB', 'VEGFA']",0.9986176690476926,0,0,9
434,Integrated Cancer Pathway WP1971,0.8342195280974237,0.6506875,0.11794276262746506,"['BARD1', 'CDKN1A', 'SMAD3']",0.999991619306454,0,0,3
435,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.83954864900949,0.691955369744095,0.12101666565656338,"['STMN1', 'STAT3', 'FN1', 'HRAS', 'ANGPTL1']",0.999991619306454,0,0,5
436,Hedgehog Signaling Pathway Netpath WP47,0.8439734612564278,0.5424989596337911,0.09202639269084768,['SAP18'],0.999991619306454,0,0,1
437,IL-9 signaling pathway WP22,0.8439734612564278,0.5424989596337911,0.09202639269084768,['STAT3'],0.999991619306454,0,0,1
438,Omega-3/Omega-6 FA synthesis WP4723,0.8439734612564278,0.5424989596337911,0.09202639269084768,['PLA2G5'],0.999991619306454,0,0,1
439,PPAR-alpha pathway WP2878,0.8439734612564278,0.5424989596337911,0.09202639269084768,['DBI'],0.999991619306454,0,0,1
440,Riboflavin and CoQ disorders WP5037,0.8439734612564278,0.5424989596337911,0.09202639269084768,['RFK'],0.999991619306454,0,0,1
441,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8439734612564278,0.5424989596337911,0.09202639269084768,['F3'],0.999991619306454,0,0,1
442,Hepatitis B infection WP4666,0.8462461296680366,0.7645210189669834,0.12763298312833443,"['CDKN1A', 'SMAD3', 'ATP6AP1', 'YWHAB', 'STAT3', 'IRF7', 'NFATC2', 'CYCS', 'PIK3CD', 'TAB2', 'HRAS', 'YWHAZ']",0.999991619306454,0,0,12
443,Sphingolipid pathway WP1422,0.8482173118966599,0.591618874567032,0.09739135963522888,"['UGCG', 'SERINC1']",0.999991619306454,0,0,2
444,Regulation of toll-like receptor signaling pathway WP1449,0.8521132945348008,0.7223267154301637,0.11559812378779959,"['IFNAR2', 'TOLLIP', 'PELI3', 'IRF7', 'PELI1', 'SPP1', 'PIK3CD', 'TAB2']",0.999991619306454,0,0,8
445,RANKL/RANK signaling pathway WP2018,0.8550195578701951,0.65046904315197,0.10188357481099274,"['TNFRSF11B', 'TAB2', 'GAB2', 'ICAM1']",0.999991619306454,0,0,4
446,Pathways affected in adenoid cystic carcinoma WP3651,0.862630116122012,0.6635845827692779,0.0980574174634155,"['MORF4L1', 'NOTCH1', 'MYCBP', 'ERBIN', 'HRAS']",0.999991619306454,0,0,5
447,Glycosylation and related congenital defects WP4521,0.8641357057486267,0.5658420009233359,0.0826273360238074,"['SRD5A3', 'MGAT2']",0.999991619306454,0,0,2
448,Glycosaminoglycan degradation WP4815,0.8647620912486866,0.5007202535292423,0.07275507789886398,['IDS'],0.999991619306454,0,0,1
449,Nanomaterial induced apoptosis WP2507,0.8647620912486866,0.5007202535292423,0.07275507789886398,['CYCS'],0.999991619306454,0,0,1
450,Hedgehog Signaling Pathway WP4249,0.8753730265994588,0.5913636363636363,0.07871355578747004,"['EVC2', 'CCND2', 'BOC']",0.999991619306454,0,0,3
451,PDGF Pathway WP2526,0.8753730265994588,0.5913636363636363,0.07871355578747004,"['SHC1', 'STAT3', 'HRAS']",0.999991619306454,0,0,3
452,Melatonin metabolism and effects WP3298,0.8785085884664279,0.5422132000832813,0.07023265627426516,"['CAMK2A', 'APOE']",0.999991619306454,0,0,2
453,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8785085884664279,0.5422132000832813,0.07023265627426516,"['CAMK2A', 'CALM3']",0.999991619306454,0,0,2
454,Constitutive Androstane Receptor Pathway WP2875,0.8827823519657774,0.4649099340110576,0.05796338791497543,['CYP3A5'],0.999991619306454,0,0,1
455,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8827823519657774,0.4649099340110576,0.05796338791497543,['PLA2G5'],0.999991619306454,0,0,1
456,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.8827823519657774,0.4649099340110576,0.05796338791497543,['EIF1'],0.999991619306454,0,0,1
457,Pregnane X receptor pathway WP2876,0.8827823519657774,0.4649099340110576,0.05796338791497543,['CYP3A5'],0.999991619306454,0,0,1
458,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8827823519657774,0.4649099340110576,0.05796338791497543,['MDH1'],0.999991619306454,0,0,1
459,Triacylglyceride synthesis WP325,0.8827823519657774,0.4649099340110576,0.05796338791497543,['MOGAT1'],0.999991619306454,0,0,1
460,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8914650833329809,0.520474703310431,0.059796822688470315,"['IFNAR2', 'IRF9']",0.999991619306454,0,0,2
461,Intraflagellar transport proteins binding to dynein WP4532,0.8914650833329809,0.520474703310431,0.059796822688470315,"['DYNLT3', 'DYNLL2']",0.999991619306454,0,0,2
462,Amino Acid metabolism WP3925,0.8968376971812351,0.6393134668487019,0.06960868866547266,"['LDHA', 'WARS', 'MDH1', 'MDH2', 'P4HA2', 'GCLM']",0.999991619306454,0,0,6
463,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8968376971812351,0.6393134668487019,0.06960868866547266,"['EGF', 'STAT3', 'PIK3CD', 'NRG1', 'MAP3K14', 'IGF1R']",0.999991619306454,0,0,6
464,Netrin-UNC5B signaling pathway WP4747,0.8975129791196468,0.5574642857142857,0.06027732954663789,"['UNC5B', 'CCL2', 'ICAM1']",0.999991619306454,0,0,3
465,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8975129791196468,0.5574642857142857,0.06027732954663789,"['NFATC2', 'PRKCQ', 'MAP3K14']",0.999991619306454,0,0,3
466,Proteoglycan biosynthesis WP4784,0.8984026997700172,0.4338743237619642,0.04648393722756487,['B3GALT6'],0.999991619306454,0,0,1
467,Transcription co-factors SKI and SKIL protein partners WP4533,0.8984026997700172,0.4338743237619642,0.04648393722756487,['TEAD3'],0.999991619306454,0,0,1
468,ATM Signaling Network in Development and Disease  WP3878,0.9071982206480672,0.5419270833333333,0.052780612930273016,"['RASGRF1', 'HSPB1', 'CDK5R1']",0.999991619306454,0,0,3
469,Splicing factor NOVA regulated synaptic proteins WP4148,0.9071982206480672,0.5419270833333333,0.052780612930273016,"['EPB41L3', 'GRIK2', 'PRKCZ']",0.999991619306454,0,0,3
470,Methionine De Novo and Salvage Pathway WP3580,0.91194257797025,0.40671816479400746,0.03749057015517522,['TXN'],0.999991619306454,0,0,1
471,ATM Signaling Pathway WP2516,0.9136101133643832,0.4818284868253638,0.0435338640569031,"['CDKN1A', 'GADD45A']",0.999991619306454,0,0,2
472,Eukaryotic Transcription Initiation WP405,0.9160463831087886,0.5272297297297297,0.046231867642036586,"['POLR2E', 'POLR2I', 'POLR2K']",0.999991619306454,0,0,3
473,Mesodermal commitment pathway WP2857,0.9185694490709333,0.6567324094568113,0.05578138357807039,"['SMAD1', 'ARL4A', 'SMAD3', 'PRKAR1A', 'FZD4', 'PBX3', 'HMGA2', 'RPL38', 'HPRT1']",0.999991619306454,0,0,9
474,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9230750441136524,0.6832511826391875,0.05469066546853528,"['RAB3A', 'SHC1', 'CFL1', 'RPS6', 'RASGRF1', 'CAMK2A', 'STAT3', 'SPP1', 'IRS2', 'EEF2', 'HRAS', 'CDK5R1']",0.999991619306454,0,0,12
475,Ebstein-Barr virus LMP1 signaling WP262,0.9236789329725271,0.3827568480575751,0.03038735050276436,['MAP3K14'],0.999991619306454,0,0,1
476,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9236789329725271,0.3827568480575751,0.03038735050276436,['RPS6'],0.999991619306454,0,0,1
477,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9236789329725271,0.3827568480575751,0.03038735050276436,['ETV6'],0.999991619306454,0,0,1
478,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9236789329725271,0.3827568480575751,0.03038735050276436,['MAP1LC3A'],0.999991619306454,0,0,1
479,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9236789329725271,0.3827568480575751,0.03038735050276436,['MDH2'],0.999991619306454,0,0,1
480,Glycerolipids and Glycerophospholipids WP4722,0.9338518648721907,0.36145789984741294,0.024737259207976408,['PNPLA3'],0.999991619306454,0,0,1
481,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9338518648721907,0.36145789984741294,0.024737259207976408,['CCND2'],0.999991619306454,0,0,1
482,IL-7 signaling pathway WP205,0.9338518648721907,0.36145789984741294,0.024737259207976408,['STAT3'],0.999991619306454,0,0,1
483,Signal Transduction of S1P Receptor WP26,0.9338518648721907,0.36145789984741294,0.024737259207976408,['GNAI1'],0.999991619306454,0,0,1
484,Vitamin D in inflammatory diseases WP4482,0.9338518648721907,0.36145789984741294,0.024737259207976408,['SMAD3'],0.999991619306454,0,0,1
485,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.93816730531342,0.487546875,0.03111864561832806,"['PIK3CD', 'HRAS', 'GRM1']",0.999991619306454,0,0,3
486,Wnt Signaling Pathway WP363,0.93816730531342,0.487546875,0.03111864561832806,"['GSK3A', 'SOX1', 'NFATC2']",0.999991619306454,0,0,3
487,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9390150885375047,0.43352071621902977,0.027278741005265703,"['CCL2', 'MAP3K14']",0.999991619306454,0,0,2
488,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9426695269240498,0.34240094618568895,0.020215182860235055,['CCL2'],0.999991619306454,0,0,1
489,Nanoparticle triggered autophagic cell death WP2509,0.9426695269240498,0.34240094618568895,0.020215182860235055,['MAP1LC3A'],0.999991619306454,0,0,1
490,Sphingolipid Metabolism (general overview) WP4725,0.9426695269240498,0.34240094618568895,0.020215182860235055,['UGCG'],0.999991619306454,0,0,1
491,Integrin-mediated Cell Adhesion WP185,0.9455101893582505,0.5647545669870137,0.03164354529101218,"['CAPNS1', 'CAV3', 'SHC1', 'PAK3', 'HRAS', 'VCL']",0.999991619306454,0,0,6
492,Target Of Rapamycin (TOR) Signaling WP1471,0.9457760574284896,0.4194958795913844,0.0233866703186777,"['FKBP1A', 'HMGCR']",0.999991619306454,0,0,2
493,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9497750982515817,0.4642410714285714,0.023922370774507436,"['RNF125', 'IRF7', 'PIN1']",0.999991619306454,0,0,3
494,Fluoropyrimidine Activity WP1601,0.9503123742074677,0.3252496878901373,0.016576198607872638,['DHFR'],0.999991619306454,0,0,1
495,Sphingolipid Metabolism (integrated pathway) WP4726,0.9503123742074677,0.3252496878901373,0.016576198607872638,['UGCG'],0.999991619306454,0,0,1
496,Copper homeostasis WP3286,0.9518189401190545,0.4063475952529669,0.020065627609636753,"['ATOX1', 'SOD1']",0.999991619306454,0,0,2
497,Ethanol effects on histone modifications WP3996,0.956936846896547,0.3097318827655906,0.013633740974856895,['DHFR'],0.999991619306454,0,0,1
498,Rett syndrome causing genes WP4312,0.9593242033173359,0.4430539772727273,0.01839834687061618,"['SCN2A', 'GABRD', 'SYNE2']",0.999991619306454,0,0,3
499,MTHFR deficiency WP4288,0.9626785647013707,0.2956247871978209,0.011244298160155222,['CYCS'],0.999991619306454,0,0,1
500,Physiological and pathological hypertrophy of the heart WP1528,0.9626785647013707,0.2956247871978209,0.011244298160155222,['STAT3'],0.999991619306454,0,0,1
501,Glycerophospholipid Biosynthetic Pathway WP2533,0.9676550964638332,0.28274439559246595,0.009296511461861402,['PIK3CD'],0.999991619306454,0,0,1
502,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9719683610160477,0.2709373699542239,0.007703298196942558,['HRAS'],0.999991619306454,0,0,1
503,Histone Modifications WP2369,0.973545739423945,0.35126694464608266,0.0094176321484116,"['SET', 'H3F3B']",0.999991619306454,0,0,2
504,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9754835074065994,0.440190373220551,0.010926416832749527,"['NOTCH1', 'RPS6', 'PRKCQ', 'HRAS']",0.999991619306454,0,0,4
505,Acute viral myocarditis WP4298,0.9762685637800396,0.3976530612244898,0.009550657296347314,"['STAT3', 'CYCS', 'ACTB']",0.999991619306454,0,0,3
506,3q29 copy number variation syndrome WP4906,0.9787318042982367,0.3896625,0.008376817368417507,"['DYNLT3', 'SLC51A', 'DYNLL2']",0.999991619306454,0,0,3
507,Thermogenesis WP4321,0.978938488741192,0.48658422041327487,0.010357659986554416,"['RPS6KA2', 'RPS6', 'ADCY2', 'HRAS', 'ACTB', 'ACTG1']",0.999991619306454,0,0,6
508,Nuclear receptors WP170,0.978946730852289,0.2500480169019495,0.005320534137881642,['RXRG'],0.999991619306454,0,0,1
509,Prion disease pathway WP3995,0.978946730852289,0.2500480169019495,0.005320534137881642,['STAT3'],0.999991619306454,0,0,1
510,Male infertility WP4673,0.9800593768958096,0.4569973029667366,0.009204894737102655,"['NQO1', 'AHR', 'TEX15', 'SOD2', 'REC8']",0.999991619306454,0,0,5
511,Fatty acid beta-oxidation WP143,0.9841885164545481,0.23214285714285715,0.0036998507270617864,['TPI1'],0.999991619306454,0,0,1
512,miRNA regulation of prostate cancer signaling pathways WP3981,0.9841885164545481,0.23214285714285715,0.0036998507270617864,['CDKN1A'],0.999991619306454,0,0,1
513,Tumor suppressor activity of SMARCB1 WP4204,0.9841885164545481,0.23214285714285715,0.0036998507270617864,['H3F3B'],0.999991619306454,0,0,1
514,mRNA Processing WP411,0.9886095197382164,0.50697725165021,0.005807854659313574,"['SF3B5', 'LSM7', 'SNRPN', 'SNRPD2', 'CELF4', 'SNU13', 'HNRNPH2', 'HNRNPA1', 'HNRNPAB']",0.999991619306454,0,0,9
515,MAPK Cascade WP422,0.9897098421481793,0.20961701099432162,0.002168166751485849,['HRAS'],0.999991619306454,0,0,1
516,Endoderm differentiation WP2853,0.9924015294298361,0.42731219938483556,0.0032593178283333636,"['NOTCH1', 'SMAD3', 'TCEAL2', 'PBX3', 'HPRT1', 'NME1']",0.999991619306454,0,0,6
517,DNA IR-damage and cellular response via ATR WP4016,0.9930888816019475,0.32440625,0.0022497932826162055,"['BARD1', 'BCL6', 'PML']",0.999991619306454,0,0,3
518,Energy Metabolism WP1541,0.9975427062154397,0.15833866203830577,0.0003895634422610621,['PPP3CC'],0.999991619306454,0,0,1
519,DNA Repair Pathways Full Network WP4946,0.9988496160008191,0.3268605959469539,0.00037623164648859707,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLE3']",0.999991619306454,0,0,5
520,Ciliary landscape WP4352,0.9992546953736263,0.45326534081251063,0.00033794670775414115,"['NDUFA5', 'WHRN', 'DYNLT3', 'CAMK2A', 'MYL6B', 'COX6C', 'DYNLL2', 'LSM4', 'MYL6', 'CDH23', 'NEFL', 'NEFM', 'MAPRE2']",0.999991619306454,0,0,13
521,Joubert Syndrome WP4656,0.9994029226697502,0.1934238861905339,0.00011552350924047872,"['CETN2', 'ARL2']",0.999991619306454,0,0,2
522,16p11.2 proximal deletion syndrome WP4949,0.9998764252036695,0.10449639563448915,1.2913918741679023e-05,['KIF22'],0.999991619306454,0,0,1
523,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999837824664385,0.13461638559233813,2.183163454084508e-06,"['EVC2', 'MKKS']",0.999991619306454,0,0,2
524,Ciliopathies WP4803,0.999991619306454,0.2176073131955485,1.8237078472454894e-06,"['EVC2', 'DNAH11', 'MKKS', 'SPAG1', 'CCDC65']",0.999991619306454,0,0,5
